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Tobacco will kill one billion (1,000,000,000) people this century, if we do nothing. It is the world’s leading preventable killer, 
driving an epidemic of cancer, heart disease, stroke, 
chronic lung disease and other non-communicable 
diseases. But the good news is: we know the most 
effective strategies for stopping it. The challenge we 
face is persuading more leaders to embrace them—
and empowering those leaders to implement them.
For almost two decades The Tobacco Atlas has been turning the most up-to-date global 
data into compelling and easy-to-understand graphics. With a changing landscape of 
products, determined industry opposition, and promising new tobacco control strategies, 
arming advocates with accurate and persuasive data has never been more important. 
Governments should act now to implement WHO’s MPOWER policies and other proven  
interventions to create a significantly healthier future. I hope, in the pages of this sixth  
edition of The Tobacco Atlas, public health advocates find new tools for spurring action.
MICHAEL R. BLOOMBERG




The sixth edition of The Tobacco Atlas celebrates recent achievements in tobacco control, illuminates the myriad harms of tobacco use, and offers a set of proven tools 
to advance a tobacco-free world. The data depict a sobering 
look at the daunting magnitude of the epidemic, but also show 
considerable progress in places where governments take up 
solutions that are proven to work. For the first time, more than 
two billion people are protected by at least one WHO MPOWER 
measure, but very few countries have taken up every measure. 
Our life-saving opportunity lies in that gap. 
In the last few years, tobacco control has been rightly seen as 
a crucial element of the movement for human development. 
In addition to saving millions of lives, tobacco control policies 
can improve livelihoods and drive enormous economic benefits by preventing the vast economic costs 
of tobacco-related diseases. Recent estimates suggest that these costs are close to a staggering two 
percent of the entire world’s gross domestic product. Imagine if we could reallocate these lost  
resources to initiatives that increase prosperity, such as improved health and education. 
We note that the ultimate path to improved tobacco control is political will. We must foster political 
will and all it portends for saving lives by prioritizing efforts that lead to action. The data are clear that 
measures like raising taxes and enacting 100% smoke-free air laws indisputably work, but too many 
governments have not yet committed to adopting them. For 
those governments that think they lack adequate resources to 
pursue effective strategies, The Tobacco Atlas demonstrates a 
significant return on investment. And for any governments that 
still listen to the arguments of the tobacco industry, which has 
long proven its indifference to health and life, The Tobacco Atlas 
systematically debunks its myths and displays its depravity.
One of the prominent themes of the Atlas is cooperation. We 
are proud that our two organizations have worked together for 
almost two decades to engender a healthier world. We urge 
governments, advocates, organizations and people who care 
about these issues to stand with us and shoulder-to-shoulder 
with the many who seek to reduce this man-made epidemic  
in pursuit of a healthier planet.
OTIS W. BRAWLEY
Chief Medical Officer,  
American Cancer Society
JOSÉ LUIS CASTRO
Executive Director, The Union 
President and CEO, Vital Strategies
6
ABOUT THE TOBACCO ATLAS AUTHORS
NEIL W. SCHLUGER, MD, is  
Senior Advisor for Science for  
Vital Strategies. He is also  
Professor of Medicine,  
Epidemiology and Environmental 
Health Science and Chief of the 
Division of Pulmonary, Allergy 
and Critical Care Medicine at  
Columbia University Medical  
Center in New York City.
JEFFREY DROPE, PhD, is Vice President, 
Economic and Health Policy Research at 
the American Cancer Society. He is also 
Professor in Residence of Global Public 
Health at Marquette University. His  
research and capacity-building efforts  
focus principally on the nexus of risk 
factors for cancer (e.g., tobacco use, poor 
nutrition and physical inactivity) and  
economic policy (e.g., taxation, trade  
and investment).
ZACHARY CAHN, PhD, is Director, Economic and Health Policy Research at the  
American Cancer Society. His principal research focus is novel tobacco products.
JACQUI DROPE, MPH, is Managing Director of Global Cancer Prevention and  
Early Detection at the American Cancer Society. She leads programs at ACS  
that focus particularly on tobacco control and HPV vaccination across many 
low- and medium-HDI countries.
STEPHEN HAMILL is Vice President of Policy, Advocacy and Communication 
at Vital Strategies, a leading global public health organization. He supports 
governments in taking up cutting-edge policies like smoke-free indoor air laws 
or soda taxes, especially in low- and medium-HDI countries where prevention 
policies can save millions of lives.
FARHAD ISLAMI GOMESHTAPEH, MD, PhD, is Strategic Director, Cancer  
Surveillance Research in Surveillance and Health Services Research at the 
American Cancer Society. His work focuses on monitoring and describing 
trends in cancer occurrence in the United States and worldwide. He also  
conducts and collaborates on research on cancer disparities and cancer  
risk factors, particularly tobacco smoking.
ALEX LIBER, MSPH, is a Data Analyst in the Economic and Health Policy  
Research program at the American Cancer Society and a PhD Candidate  
at the University of Michigan’s School of Public Health. Using multiple  
methodologies, his research focuses on issues in tobacco control policy and 
surveillance, including novel tobacco product regulation, tobacco pricing,  
and health insurance.
NIGAR NARGIS, PhD, is Director, Economic and Health Policy Research at the 
American Cancer Society. Her research and capacity-building efforts focus  
on issues related to tobacco taxation, tobacco affordability, tobacco use  
and poverty, and regressivity in some tobacco control policies. 
MICHAL STOKLOSA, MA, is Senior Economist, Taxation & Health in the  
Economic and Health Policy Research program at the American Cancer  
Society, and a PhD Candidate in Economics at the University of Cape Town.  
He conducts research and trains policymakers and health advocates primarily 





It is with great passion and renewed urgency that we bring you the sixth edition of The Tobacco Atlas. 
In the 18 years since the first edition, there have been many positive changes in tobacco control: 
overall tobacco consumption has finally started to edge down, though this change is uneven across 
the globe. The WHO Framework Convention on Tobacco Control now has 181 parties and has truly 
become a vital blueprint for change.
Yet, tobacco use is increasing in some countries and within some sub-populations, particularly 
among the most vulnerable. We are launching this edition at the 2018 World Conference on Tobacco 
or Health in South Africa, on a continent that is a principal target of the tobacco industry’s vigorous 
efforts to recruit new users. More broadly, the tobacco industry continues its nearly unfettered assault 
on public health. Some governments, despite having tools to improve tobacco control, continue to 
struggle to effect change, sometimes because of competing priorities, but in other cases simply due 
to a lack of effort. 
In this edition, we first lay out the case for tobacco control. The death and destruction that follows 
in the wake of tobacco use is simply mind-boggling. But in the second half of the Atlas, we strive to 
emphasize the proven solutions that many in the public health community are actively utilizing with 
considerable success.
We are deeply grateful to our author/editor predecessors, both for atlas-style publications generally, 
and The Tobacco Atlas specifically. We particularly thank Judith Mackay and Michael Eriksen who were 
the early visionaries for this series—we hope that we have made them proud with this latest edition.
We are also extremely grateful to our organizations, the American Cancer Society and Vital Strategies, 
for their unwavering commitment to tobacco control and The Tobacco Atlas. 
To save space in this print edition for content and to have more resources to pour into a dynamic  
website, the references are kept at www.tobaccoatlas.org (or www.ta6.org). We strongly encourage 
readers to visit our website for country fact sheets, considerable new content, frequent updates  
and comprehensive data, among other components.
In sum, we underscore here that while we continue to face a very serious challenge, we have the tools 
to make an enormous positive difference. We must persuade decision-makers to make decisive, 
meaningful change, and where necessary, assist them to fight vigorously to implement these proven 
tools and enforce them. Finally, to achieve and sustain our shared goals, we are stronger working  
together— and we implore readers to seek out synergies with other forces to make sure tobacco 
control helps lead to a healthier, tobacco-free future.
Sincerely,
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It takes many people to make a project like The Tobacco Atlas come together. At risk of excluding 
people who helped us along the way, we would like to acknowledge some very key actors.
First and foremost, Johnny Hsu at Vital Strategies and John Daniel at ACS might not have officially 
authored any chapters, but their roles were enormous and integral. Johnny anchored our design 
vision among many other tasks, while John went far beyond his official editorial responsibilities. 
The Atlas is a better product because of them.
At ACS, many folks played important roles. In terms of data and content preparation, we thank 
Samuel Asare, Martine Chaussard, Qing Li, and Nikisha Sisodiya. We couldn’t have completed the 
project without the administrative and financial prowess of Nancy Inglis-Wesby and Shacquel 
Woodhouse, and the printing and publication expertise of Vanika Jordan. At Vital Strategies, we 
thank Christina Curell and Dane Svenson, but especially Tracey Johnston for her communications 
savvy among many other talents. Bob Land once again delivered an excellent index.
We are indebted to our talented design partners at Radish Lab. They were engaging, creative  
and hardworking every single day, including Hege Bryn (design), Kendall Holland (project  
management), and Eric Brelsford (data visualization). 
We were a little skeptical about a publication anchored by illustrations, but Daniel Stolle has  
simply wowed us with his phenomenal vision and creativity. We are grateful for this new,  
wonderful twist to the Atlas.
We’d like to thank the leadership at both organizations. At ACS, our CEO Gary Reedy and CMO  
Otis Brawley, have strongly supported this publication. Similarly, at Vital Strategies, SVP Sandy 
Mullin has been a fervent supporter, as has the Union’s Executive Director, José Luis Castro. 
As we mention in the preface, we remain grateful to Michael Eriksen and Judith Mackay for  
their work on previous Atlases, and for their continuing support and collegiality.
Many colleagues generously helped along the way, including data, input, feedback, etc. on many 
chapters, including: Growing (Raphael Lencucha, Qing Li, and for the satellite images, Liora 
Sahar and Nick Faust); Manufacturing (Qing Li); Marketing (Lindsey Liber); Quitting (Martin Raw); 
Partnerships (Martine Chaussard and Mônica Andreis); Regulating Novel Products (Joanna Cohen, 
Ryan Kennedy, Robert Jackler, Cindy Chau and Divya Ramamurthi); Industry (Stella Bialous); and 
Countering the Industry (Deborah Arnott, Rob Cunningham and Holly Jarman).
For broader data needs, we thank the Institute for Health Metrics and Evaluation (IHME),  
particularly Emmanuela Gakidou, for generously permitting us to use many of their fantastic  
data to populate a number of maps and figures. 
Any shortcomings, of course, are our own.
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INTRODUCTION
By now, we know that tobacco kills more than half of those who regularly use it and has a two- 
trillion-dollar (purchasing power parity (PPP)) economic cost to society each year. Fortunately, the 
global community is making progress toward improving tobacco control. The efforts of governments, 
civil society and the international community, including through the WHO Framework Convention on 
Tobacco Control (FCTC), are having life-saving effects in many countries. Recently, overall global  
tobacco consumption has even decreased slightly. However, we continue to contend with the reality 
that many countries with young populations are experiencing growing prevalence as the tobacco 
industry’s tactics continually undermine public health efforts.
This sixth edition of the Tobacco Atlas and its companion website— tobaccoatlas.org— bring readers 
and users an exciting and comprehensive guide to key tobacco control issues. It weaves together two 
related narratives: the bleak reality of the damage that tobacco causes even before it sprouts from the 
ground, and an optimistic examination of the evidence-based tools that we’re using to address this 
reality, which could be further enhanced through more effective implementation.
We begin the narrative with cultivation of tobacco leaf, the foundation of every tobacco product. Here 
commences an enduring narrative of ill health and exploitation, in this case of the millions of mostly 
poor smallholder tobacco farmers. The tobacco industry turns the leaf into a variety of deadly tobacco 
products— most commonly cigarettes— and aggressively markets them, particularly to young people 
and other potentially vulnerable groups. In recent years, seeing opportunities in the lower prevalence 
among women and girls, and in many countries/regions low on the human development index (HDI), 
the industry has tailored its marketing efforts in this direction. It also continues to target many  
vulnerable populations in all countries. Accordingly, we explore global smoking and secondhand 
smoke prevalence followed by their results: adverse health effects, comorbidities, deaths from  
tobacco, and the broader costs to society. 
The second half of the Atlas is more optimistic, focusing on the proven tools and strategies that we  
use to address the tobacco epidemic at almost every stage of the cycle of a tobacco product. These  
interventions include cessation efforts, marketing bans, smoke-free policies, tobacco taxes and mass 
media campaigns, among others. The market for tobacco products is also shifting in unpredictable 
ways. Some are optimistic that new non-combustible products that are potentially less harmful will 
diminish the market size of cigarettes and other combustible tobacco products. Others are  
understandably cautious about the uncertainty and any approach that involves tobacco  
companies, given their long history of deception and malfeasance.
The book can be read as a whole— a comprehensive narrative of the complete “cycle of tobacco”— 
or each chapter can be read on its own as a core component of this narrative. Importantly, we have 
developed a new, more dynamic companion website to 1) provide comprehensive, up-to-date data 
coverage; 2) address other important topics that we lack space to cover here (e.g., smokeless tobacco 
and water pipes); and 3) offer a place where we will regularly introduce timely and relevant new  
content. We hope the Tobacco Atlas will inspire you to action to improve tobacco control in your  
country, and will provide helpful guidance on the many tools to achieve these goals.
Instead of categorizing countries 
by income in the Atlas, we use 
the Human Development Index 
(HDI) because it moves beyond 
income to incorporate additional 
critical indicators such as health 
and education.
www.tobaccoatlas.org/methods
FIND OUT MORE AT
     Fewer Smokers; Fewer Premature 
Deaths; $ Saved
If we meet the WHO’s very tractable goal of  
a 30% relative reduction in each country  
by 2025, we would:
Imagine if we set an even more ambitious target...
WebInset Map
1. Have 173 million fewer smokers
2. Prevent 38 million premature deaths from smoking
3.  Save $16.9 trillion (PPP) just from the former 
smokers becoming healthier and more productive.
CHAPTER KEY
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     Wheel of Tobacco Regulation
Growing 
Governments must help to improve 
supply and value chains for alternatives 
to tobacco leaf, and invest in farmers’ 
education/re-training programs.
Product Use 
Policies should make all 
indoor, workplace and 
public outdoor spaces 
smoke-free, and find 
effective, new ways to 
keep smokers from  
smoking in their homes 
with non-smokers.
Disposal 
Get the tobacco industry 
to bear the cost of  
cleaning up the 
environmental  
devastation from the 
waste left by tobacco 
production and use.
Manufacturing 




Plain, standardized  
packaging of all  
tobacco products.
Marketing  
Ban all direct and 
indirect forms of 
marketing, including 
advertising,  
promotion and  
sponsorship.
Tax Policies 
Implement higher excise taxes on 
all tobacco products and make 
certain that increases outpace 
inflation and income growth.
Point-of-Purchase 
Eliminate all signs and even 
hints of tobacco product sales, 
including keeping them out  




A ll tobacco products start with a simple leaf. The cultivation of tobacco leaf,  indigenous to the Americas, dates back 
at least eight millennia, and tobacco smoking for 
at least two. In the 15th century, Columbus helped 
shape the future of the tobacco industry as the 
first “importer” of tobacco into Europe. Within  
decades, tobacco had spread globally, including 
cultivation for commercial purposes. Mechani-
zation of cigarette manufacturing in the 1880s 
helped grow the market for cigarettes drama- 
tically, increasing demand for tobacco leaf . 
While widespread cultivation of tobacco leaf has 
generated many challenges— including health 
hazards for farmers, environmental degradation 
  and child labor issues—the most pressing  
systemic public health challenge is how the 
industry often uses tobacco farming to under-
mine tobacco control, arguing that tobacco 
control destroys the livelihoods of smallholder 
tobacco farmers. This specious argument—often 
perpetuated by governments’ economic and/
or agribusiness sectors—has resonated widely, 
undermining tobacco control efforts around the 
globe. Not coincidentally, tobacco farming has 
also shifted to some of the world’s lowest-HDI 
countries, where governments are typically  
more economically and politically vulnerable .
Recent research across major tobacco-growing 
countries demonstrates that farming tobacco is 
not prosperous for most smallholder farmers. 
Many farmers—including many with contracts 
with oligopolistic leaf-buying companies—pay too 
much for inputs (e.g., fertilizer, pesticides, etc.), 
 receive very low prices for their leaf, and dedicate 
hundreds of hours to a mostly unprofitable 
economic pursuit . The opportunity costs of 
farming tobacco are high, with farmers missing 
out on human capital development and  
more lucrative economic opportunities.
So why do tobacco farmers grow tobacco? Many 
farmers report an assured market, even if prices 
are consistently low. Others report difficulty 
obtaining credit for other economic activities. 
For some, it is a way to generate cash in low-cash 
economies to pay for necessities like education 
and health care. Yet, the research demonstrates 
consistently that many tobacco farmers underesti-
mate their costs and overestimate their returns.
Article 17 of the WHO FCTC compels Parties to 
promote viable alternative livelihoods for tobacco 
farmers. Few governments have made such  
efforts. There is no panacea for this transition; 
some countries have tried small programs to  
introduce new crops—e.g., bamboo in Kenya 
(with mixed results). Some farmers switch to and 
from tobacco, based on hopes for high leaf prices. 
The most successful larger-scale examples of 
change rely more on existing skills and experience. 
In Indonesia, former tobacco farmers are growing 
non-tobacco crops that they have always grown, 
and are making more money doing so .  
Governments can help by investing in supply and 
value chains, finding new markets for these other 
products, and divesting from any participation  
in tobacco cultivation. They can also re-invest 
vigorously in education and skills development, 









FIND MORE ONLINE ta6.org/growing
Smallholder Tobacco Farmer Profits 
In the last few decades, China has come to dominate tobacco production, but 
notably production has dropped markedly in very high-HDI countries and 
increased everywhere else.
Tobacco Leaf Production 
by HDI, 1960-2014
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Tobacco Production by Volume 
Metric tons, 2014
Northern Region, Malawi 
1992-2015 (2015 Landsat 8 image)
Western Tabora Region, Tanzania 
1999-2017 (2017 Landsat 8 image)
VEGETATION LOSS
     Alternative Livelihoods 
Indonesia Example
    Environmental Degradation from Tobacco Farming
Note: The circles indicate the size of sales of the crops. 
Former tobacco farmers are growing more of most other local 
crops, making more money and spending less time in their fields 














Farmers who stopped growing tobacco









In many countries, farmers clear forested land that is agriculturally marginal to grow tobacco—often by burning —and/or 







 Explore more at ta6.org/growing
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Once raw tobacco leaf has been grown by a farmer and sold to a manufacturer, it must be processed into a desirable 
consumer product. To maximize profits, tobacco 
manufacturers want to make products that 
are as attractive and addictive as possible. The 
product standards governing this process of 
transformation aim to control tobacco products’ 
characteristics and which kinds of tobacco  
products can be sold to consumers. 
When these standards are written with public 
health in mind, tobacco products can be  
mandated to be less attractive and less  
addictive to users. Such strategies include bans 
on characterizing flavors, limits on nicotine 
content, and prohibitions against additives that 
quicken nicotine’s absorption into the body. 
Additional policies include freezing the tobacco 
market by preventing the introduction of  
new brands, restricting a brand to a single  
presentation to prevent implicit suggestions 
of reduced harm in variants, and requiring the 
disclosure of ingredients to regulatory  
agencies and consumers.
Banning the addition of menthol, the most  
widely used flavor in tobacco products, has  
considerable potential to curb smoking.  
Research suggests that menthol in cigarettes 
may facilitate initiation and hinder quitting.  
Fortunately, laws banning the sale of menthol  
in tobacco products have passed in Brazil,  
Turkey, Ethiopia, the European Union,  
and five Canadian provinces.  
While manufacturing standards that limit the 
appeal and addictiveness of products hold the 
promise of shrinking the tobacco market in the 
long run, there can be unintended consequences 
if such regulations do not carefully consider 
the broader tobacco product marketplace. For 
example, the market position of existing varieties 
of cigarettes became solidified when they were 
exempted from pre-market scrutiny under the 
United States’ law extending the Food and Drug 
Administration’s jurisdiction to cover tobacco 
products. Cigarette manufacturers were  
permitted to keep selling a deadly consumer 
product with only some restrictions, while  
barriers to the introduction of new potentially 
less harmful products were codified. 
Meanwhile, the global tobacco industry has 
recently consolidated through privatization,  
acquisitions and mergers—now only 5 firms 
control 80% of the global cigarette market.  
These firms have automated and consolidated 
their own factories, steadily driving down the 
number of employees. Hence, now more than 
ever, when tobacco companies say that tobacco 
control policies threaten manufacturing  
jobs , we must remember that they are only  
in the business of maximizing their profits for  
shareholders, not protecting the well-being  










FIND MORE ONLINE ta6.org/manufacturing
    Factory Consolidation
British American Tobacco closes factories, putting  
people out of work while handing over increasing  
gains to wealthy shareholders and executives


































































World’s Largest-Producing Tobacco Product Factories
Where disease originates
Resilience Facing Factory Closure
In 2016, British American Tobacco announced it would 
close its Petaling Jaya, Malaysia factory to consolidate 
manufacturing regionally, blaming high excise taxes 
on cigarettes. Malaysia did not bow to industry  
pressure to change its laws to try to save a factory.
Mandatory De-Nicotinization 
The United States FDA has begun proposing a  
rule mandating cigarette manufacturers lower  
nicotine levels to non-addictive or minimally  
addictive levels, potentially preventing millions 
from becoming addicted. 
Free Trade Zone Cigarette Factories
One-third of illicit cigarette manufacturing facilities 
are located in free trade zones of the United Arab 
Emirates, Cyprus, and Russia, producing cigarettes 
that are smuggled into third-party countries,  
undermining tobacco control policy. 



















 Explore more at ta6.org/manufacturing
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Once a product rolls off the manu- facturing line, it needs help to get to consumers. Tobacco companies must 
build the demand for products, particularly 
from new consumers. Marketing creates consumer 
 demand, essentially inventing the reasons why 
a person would want to smoke a cigarette or use 
other tobacco products. Controlling the ability  
of the tobacco industry to spread favorable ideas 
about tobacco use is the essence of tobacco 
control efforts to regulate marketing. Closing off 
marketing channels to everyone has the primary 
benefit of shielding children from persuasive 
efforts that influence them to start smoking. 
While the tobacco industry always claims that 
their advertisements are not intended to appeal 
to children, they walk a fine line by aiming their 
marketing efforts to young adults, a group who 
children see as their closest peers and role models. 
Sometimes, such as by marketing tobacco like 
candy, tobacco companies cross this line.
The tobacco industry has found creative ways to 
market its products, including through attractive 
packaging and so-called “corporate social 
responsibility” campaigns wherein they seek 
to present themselves as positive contributors 
to society. Regulating these myriad marketing 
strategies is a central tobacco control strategy. 
Essentially, wherever the tobacco industry tries  
to change the message about what their 
products represent away from disease and 
death, tobacco control attempts to change the 
conversation firmly back to the essential facts of 
tobacco use: disease and death.
Tobacco companies typically respond to  
marketing restrictions by reallocating resources 
to the remaining open channels. For example, 
when the government prohibits magazine and 
billboard advertising, the industry simply moves 
to other strategies, such as direct mail, internet, 
point of sale, package branding and discounting.  
When regulation successfully eliminates all 
channels, the tobacco market will freeze up 
and dwindle over time. But we know that until 
every single channel for marketing is closed off, 
tobacco companies will try to spend their way 
around the problem because there is money to 
be made doing so. Thus, tobacco control must 
work relentlessly toward closing off every avenue 
available to tobacco companies to promote their 
destructive products. Such innovative anti- 
marketing efforts include requiring plain,  
standardized packaging of their products,  










FIND MORE ONLINE ta6.org/marketing
Progress on Bans and Warnings 
Percent of Global Population Covered by FCTC Marketing Policies 
(graphic health warnings (GHW) on packages, point-of-sale (POS)  
advertising ban, and internet marketing ban)
















































FCTC Compliance with Marketing 
Bans Across the Globe
This mockup of a bilingual point-of-sale advertising 
ban envisions what this policy would look like if  
adopted in Hong Kong. As of 2016, 15% of the 
world’s population, living in 37 countries, were 
covered by the WHO FCTC’s best-practice policy 
of banning tobacco advertising, promotion and 
sponsorship. Of the world population, 47%  
(in 78 countries) were covered by a tobacco  
health warning label that met best practices. 
Plain, Standardized Packaging  
and Products
When tobacco companies responded to Australia’s 
plain packaging law by adding distinctive markings 
to cigarettes, they were reprimanded as being  
“not strictly compliant” with current legislation.  
As a potentially important improvement on plain 
packaging legislation, Canada has considered 
standardizing the entire cigarette, going to a plain 
product, requiring wrapping the cigarette in an 
unpleasant color of paper.
Surreptitious Promotion of Smoking 
Through E-Cigarette Adverts 
Allowing for e-cigarettes ads that surreptitiously 
promote smoking in channels that are closed off 
to tobacco products. Philip Morris manufactures 
MarkTen e-cigarettes, which look nearly identical 
to cigarettes here as “smoke” floats off the end of 
the e-cigarette. Companies can claim they are only 
advertising e-cigarettes where cigarette ads have 
been banned, even though the products are  
indistinguishable to the viewer.
GOOD PRACTICE CUTTING EDGE PRACTICEBAD PRACTICE
Advertising Bans






Warning labels  
>50% of pack size
Plain, standardized 
packaging and  
large graphic  
warning labels












Percentage of Adult Males Who Smoke Daily
Age ≥10, 2015 or latest data available
G lobally, 942 million men and 175 million women ages 15 or older are current smokers. Nearly three quarters of male daily 
smokers live in countries with a medium or high 
human development index (HDI), whereas half of fe-
male daily smokers live in very high-HDI countries . 
Male smoking prevalence in most medium- to very 
high-HDI countries substantially increased in the past 
century, though this generally happened earlier in 
very high-HDI countries (the first half vs. second half 
of the 20th century). Almost all very high-HDI  
countries saw a significant decrease in male smoking 
after the 1950s. Many medium- or high-HDI countries 
have also seen a decline in prevalence, but mostly a 
relatively moderate one from the beginning of this 
century. Smoking prevalence has been historically 
modest in most low-HDI countries, though this still 
translates into tens of millions of smokers.  
Female smoking prevalence in very high-HDI coun-
tries peaked a few decades later than the peak in 
male smoking, but it has remained relatively low or 
had a moderate increase thus far in other countries.
However, the earlier decreasing trend in smoking 
prevalence in most very high-HDI countries has 
stalled in recent years, and smoking prevalence  
has continued to rise or remained at high levels in 
many medium- or high-HDI countries. Further, some 
low-HDI countries (e.g., in sub-Saharan Africa) have 
seen a recent increase in prevalence . This trend  
is likely to occur in many other low-HDI countries in 
the future because of income growth and increasing  
cigarette affordability, as well as the tobacco 
industry’s strategy of aggressive marketing in those 
countries, unless governments implement stronger 
tobacco control policies, including raising taxes  
to increase prices of tobacco products. 
Another major concern is a recent increase in smoking 
prevalence among youth, particularly among females, 
in several low- to high-HDI countries, in some of which 
smoking among adolescent girls is now more common 
than among adult women or even adolescent boys. 
Nearly two thirds of countries, including 98% of  
low-HDI countries and 93% of countries in sub- 
Saharan Africa, have not implemented tobacco  
use monitoring at best-practice level . Effective 
monitoring at the national level must be a priority  
for governments, as this is essential for estimating 
the tobacco-related burden and evaluating the 
success of tobacco control policies.
Although tobacco use remains a major health issue 
worldwide, the declines in prevalence in countries 
with active tobacco control efforts demonstrate that 
we can reduce smoking with effective strategies. 

























 Explore more at ta6.org/prevalence
Countries with daily 
smoking prevalence 
of ≥10% among 
females: age ≥10, 
2015 or latest data 
available
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  Global Distribution of Smokers
Three quarters of male daily smokers live in countries 
with medium or high-HDI, whereas half of female  




















Low HDI Medium HDI High HDI Very High HDI
Male and female daily smokers globally, age ≥10 years, 2015,  






































    Recommended Level of  
Tobacco Monitoring 
Many countries, particularly lower-HDI countries, lack 
an appropriate system for monitoring tobacco use
Annual cigarette consumption and percentage of change 
1980–2016, by WHO region 
Changes in Consumption 
Due to combination of population growth and  
increase in smoking rates, cigarette consumption  
in several WHO regions has substantially  
increased in recent decades






































 Read the web-only chapter: ta6.org/consumption
Trends in current tobacco smoking among males aged 15 years and over in select African countries
     Smoking in Africa
Several sub-Saharan countries have seen a recent increase in smoking prevalence







































In 2016, an estimated one-fifth of males and one-third of females globally were exposed to secondhand smoke. Although secondhand 
smoke usually comes from cigarettes, smoking 
other tobacco products (such as waterpipe) is 
common in some populations and can substan-
tially contribute to secondhand smoke exposure. 
Exposure to secondhand smoke is associated with 
numerous adverse health effects, even among 
children and unborn babies , and causes  
substantial mortality and morbidity globally.  
In 2016 alone, for example, it caused an  
estimated 884,000 deaths. The years of life lost 
due to ill-health, disability, or early death because 
of secondhand smoke was 6.4 million years for 
lower respiratory infections, 2.5 million for chronic 
obstructive pulmonary disease, and more than 
200,000 for middle ear infection.  
Exposure to secondhand smoke is common in 
many countries, notably in Asia . In Indonesia 
and Pakistan, for example, more than 80% of 
people are exposed to secondhand smoke in 
restaurants. 
Variations in smoke-free laws and enforcement  
of these laws greatly affect levels of exposure.  
Due to these variations, prevalence of exposure  
to secondhand smoke in bars and restaurants is  
relatively low in several European Union member 
states (<10%) but is far higher in some others  
(e.g., nearly 80% in Greece in 2017) . After 
implementation of comprehensive laws in Turkey 
in 2009, exposure prevalence in work-places and 
restaurants dropped substantially— from 37% and 
56% respectively in 2008 to 16% and 13% in 2012. 
Prevalence of secondhand smoke exposure in 
many countries with a low Human Development  
Index (e.g., in sub-Saharan Africa) is low simply 
due to relatively low smoking prevalence. 
However, even those countries must implement 
or enforce existing comprehensive smoke-free 
laws to protect their populations. With current 
trends, many of them are likely to see a substantial 
increase in smoking, and consequently,  
secondhand smoke prevalence.  
Within countries, some groups demonstrate 
higher exposure levels and related burden, such 
as those of lower socioeconomic groups  and 
non-smoking women. For example, secondhand 
smoke causes more deaths in women than in men 
globally (573,000 vs. 311,000 in 2016) and more 
lung cancer deaths among women than men in 
China (40,000 vs. 12,000 in 2013). Returning to the 
example of Turkey, the decline in prevalence of 
exposure at home (from 56% to 38%) was smaller 
than the decline in public places, reinforcing  
the importance of focusing on exposure inside the 
home. In many populations, homes are the main 
place of exposure to secondhand smoke  
for women and children.
Sudden Infant  
Death Syndrome (SIDS)
Asthma (school age), wheeze  
illnesses, impaired lung function;  
lower respiratory illness  
(e.g. pneumonia); respiratory  
symptoms (e.g., cough and  
breathlessness)
Middle ear disease  
(including acute  
and recurrent infection)
CHILDREN - SUFFICIENT EVIDENCE
     Harms
Strength of evidence varies, but secondhand smoke 
is related to multiple diseases in children and adults
Stroke




Reproductive effects in 
women: low birth weight
Nasal irritation,  
odor annoyance





Chronic obstructive pulmonary disease, 
acute respiratory symptoms (including 
cough, wheeze, chest tightness, and 
difficulty breathing), chronic respiratory 
symptoms, asthma and worsening of 
asthma control, impaired lung function
Atherosclerosis






















 Exposure by  
Socioeconomic Status
Exposure to secondhand smoke from combustible 

















No university degree University
     Secondhand Smoke Prevalence
Exposure to secondhand smoke is very common in some countries




























Secondhand smoke exposure (%) in homes, indoor workplaces, and restaurants in select countries, ages ≥15,  
Global Adult Tobacco Survey, 2011-2015
     Secondhand Smoke in Europe
Secondhand smoke exposure (%) in bars and restaurants in 28 European countries, ages ≥15, 2017
0% 0%87% 78%
BARS RESTAURANTS
 Explore more at ta6.org/secondhand
Exposure to secondhand smoke (%) from cigarettes and waterpipe 






















Tobacco use is one of the most important  preventable causes of premature death in  the world. More than 6 million people per  
year die from tobacco use across the globe. There  
is no question that limiting tobacco use is one of  
the most effective ways to save lives and improve 
overall well-being. 
Smoking tobacco causes exposure to a lethal mixture 
of more than 7000 toxic chemicals, including at least 
70 known carcinogens that can damage nearly every 
organ system in the human body. Harms from tobacco 
begin before birth, as pregnant women who smoke 
give birth to infants at higher risk of congenital disor-
ders, cancer, lung diseases, and sudden death. Newly 
identified risks from smoking include renal failure, 
intestinal ischemia, and hypertensive heart disease. 
The risk of death and disease from tobacco rises with 
the number of cigarettes smoked, but damage begins 
with use of a very small number of cigarettes. A regular 
life-long smoker loses at least 10–11 years of life to 
tobacco on average. In addition, exposure to second-
hand or environmental tobacco smoke is associated 
with increased risk of cancer and heart disease,  
among other deleterious health effects.  
Lung cancer is now the leading cause of cancer death 
in the world. It has long been the leading cause of 
cancer death among men, and in many countries is 
now also the leading cause of cancer death among 
women, outpacing breast cancer. Chronic obstruc-
tive pulmonary disease (COPD) is one of the leading 
causes of death in the world, and mortality from this 
condition is increasing in most countries; globally, 45% 
of all deaths from COPD are attributed to tobacco use. 
Similarly, death from heart disease and stroke, the two 
leading causes of death in the world, are heavily tied 
to tobacco use.
Combustible tobacco use is extremely hazardous to 
human health and is responsible for more than 90% 
of tobacco-attributable death and disease, despite 
efforts by the tobacco industry to market safer- 
sounding alternatives such as low-tar cigarettes  
and water pipes.  Therefore, a top priority is to avoid 
combustible tobacco products, and the only way  
for an individual to completely eliminate tobacco- 










- Cataracts, blindness (macular degeneration)




- Infertility (sperm deformity, 
loss of motility, reduced number)
- Impotence
- Prostate cancer death
13. FEMALE REPRODUCTION
- Cervical and ovarian cancer




- Bladder, kidney, and ureter cancer
15. HANDS
- Peripheral vascular disease, 
poor circulation (cold fingers)
16. SKIN
- Psoriasis





- Susceptibility to back problems
- Bone marrow cancer
- Rheumatoid arthritis
18. WOUNDS AND SURGERY
- Impaired wound healing
- Poor post-surgical recovery
- Burns from cigarettes and from 
fires caused by cigarettes
19. LEGS AND FEET
- Peripheral vascular disease, 
cold feet, leg pain and gangrene
- Deep vein thrombosis
20. CIRCULATORY SYSTEM
- Buerger’s disease (inflammation of 
arteries, veins and nerves in the legs)
- Acute myeloid leukemia
2. BRAIN AND PSYCHE
- Stroke (cerebrovascular accident)
- Addiction/withdrawal
- Altered brain chemistry
- Anxiety about tobacco’s health effects
3. HAIR
- Odor and discoloration
4. NOSE
-  Cancer of nasal cavities and 
paranasal sinuses
- Chronic rhinosinusitis 
- Impaired sense of smell
5. TEETH
-  Periodontal disease (gum disease, 
gingivitis, periodontitis)
- Loose teeth, tooth loss
- Root-surface caries, plaque
- Discoloration and staining
6. MOUTH AND THROAT
-  Cancers of lips, mouth, throat,  
larynx and pharynx
- Sore throat 
- Impaired sense of taste
- Bad breath
7. EARS
- Hearing loss 
- Ear infection
8. LUNGS
- Lung, bronchus and tracheal cancer
-  Chronic obstructive pulmonary disease 
(COPD) and emphysema
- Chronic bronchitis 
-  Respiratory infection (influenza,  
pneumonia, tuberculosis)
- Shortness of breath, asthma 
- Chronic cough, excessive sputum production
9. HEART
- Coronary thrombosis (heart attack)
-  Atherosclerosis (damage and occlusion  
of coronary vasculature)
10. CHEST & ABDOMEN
- Esophageal cancer
- Gastric, colon and pancreatic cancer
- Abdominal aortic aneurysm
-  Peptic ulcer (esophagus, stomach,  
upper portion of small intestine)
- Possible increased risk of breast cancer




















- Impaired resistance to infection
























































Percent of DALYs Attributable to Tobacco Use
Tobacco use is responsible for a large proportion of disability-adjusted life years (DALYs) —  
the number of years lost due to ill-health, disability or early death
0% 19%
 Explore more at ta6.org/health-effects
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In the last several years, research has shown that the negative impacts that smoking has on health go far beyond lung cancer, chronic 
obstructive pulmonary disease (COPD), heart  
disease, stroke and other well-known conse-
quences of tobacco use. We now know that 
tobacco helps fuel the global epidemic of tuber-
culosis, and it worsens problems such as mental 
illness, HIV infection and alcohol abuse.
Tuberculosis (TB) is the leading cause of death 
due to a single infectious agent in the world, and 
is the 6th-leading cause of death in the world 
overall, killing 1.8 million people in 2015.  
Cigarette smoking increases the risk of  
developing TB, and it makes treatment for TB 
less effective. Worldwide TB rates could decline 
as much as 20% if we eliminated smoking.  
Persons with mental illness are more likely to 
smoke than people without such disorders, and 
it is much more difficult for them to quit. The 
more psychiatric diagnoses an individual patient 
has (among disorders such as schizophrenia, 
attention deficit disorder, bipolar illness, and 
others), the more likely it is that a person will 
smoke. For certain illnesses such as anxiety  
disorders, schizophrenia and bipolar illness, 
smoking seems to exacerbate symptoms, 
perhaps by making psychiatric medications less 
effective, and quitting smoking may improve 
symptoms as much as adding additional  
psychotropic drugs. In the US state of California, 
more than half of persons with mental disorders 
die from tobacco-related illness.  
The harmful effects of smoking are magnified 
and accelerated in patients with HIV infection 
because when these patients use tobacco, they 
develop lung cancer and airway diseases such as 
COPD at higher rates and at younger ages than 
HIV-infected non-smokers. In settings where 
primary treatment for HIV infection is widely 
available and the disease can be well-managed, 
continuing tobacco use threatens progress 
in controlling AIDS, whereas in low-resource 
settings, it undermines already challenging 









Alcohol abuse and tobacco dependence 
often coexist and have mutually-reinforcing 
harmful effects. A recent study in Russia 
demonstrated that although smoking was 
reported by “only” 14% of pregnant women, 
smoking prevalence was much higher (45%) 
among heavy drinkers and those at risk for an 
alcohol-exposed pregnancy. Thus, smoking 
and alcohol abuse co-occurred often and 
created a serious danger of dual prenatal 
exposure, with grave health consequences  
for offspring from those pregnancies.   
Although links between tobacco and other 
serious medical conditions such as TB and HIV 
infection have been increasingly recognized,  
few TB or HIV clinics integrate smoking cessation 
programs into their routine services. This is  
an urgent need that must be addressed.
Tuberculosis and Tobacco 
Percentage of tuberculosis-related  
deaths due to tobacco
Tuberculosis Mortality 
and Smoking
Independent of smoking, Africa already has among the 
largest TB challenges of any region, but models predict 
that smoking will greatly exacerbate TB mortality 
trends for the foreseeable future




































Baseline scenario Without smoking
Smoking and HIV 
As HIV-infected persons age, continued smoking robs 
them of more life than HIV-related factors










































About 1 in 3 adults with mental 
illness smoke cigarettes  
(compared to 15% of adults  
with no mental illness)
1 in 3
Mental Illness and  
Adult Smoking in  
the United States
Near 1 in 5 adults have some 
form of mental illness
1in 5
Greater smoking intensity: about 
3 in 10 cigarettes smoked by 








 Explore more at ta6.org/comorbidities











T obacco use increases the risk of death from many diseases, including ischemic heart disease, cancer, stroke, and  
respiratory diseases. In 2016 alone, tobacco use 
caused over 7.1 million deaths worldwide  
(5.1 million in men, 2.0 million in women)  .  
Most of these deaths (6.3 million) were  
attributable to cigarette smoking, followed  
by secondhand smoke (884,000 deaths). 
There is a several-decade lag between changes  
in smoking prevalence and changes in  
smoking-related death rates in the population. 
In general, countries with a very high human 
development index (HDI) have seen a decline  
in smoking prevalence at least since the 1960s, 
followed by a decrease in smoking-related 
death rates since the 1980s–90s. Nevertheless, 
the burden of smoking-related diseases, 
notably lung cancer, is still substantial in those 
countries  . Smoking-related death rates are 
expected to increase for the decades to come 
in many countries with a lower HDI, as they 
saw an increase in smoking prevalence more 
recently (the 1980s–90s or even later); in some, 
the prevalence is still increasing.  
 
In about 55 countries, at least one-fifth of all 
deaths in males are attributable to smoking. 
These countries generally are high- or very 
high-HDI countries, mostly located in Europe 
(33 countries) or the Western Pacific region (11 
countries), although there are two or more such 
countries in the other World Health Organization 
regions, except the African region  . The lower 
tobacco-related burden in Sub-Saharan Africa 
reflects its historical lower smoking prevalence. 
However, with an increase in affordability of 
tobacco products and the tobacco industry’s  
aggressive marketing in Africa, smoking  
prevalence has already started to rise, or is likely 
to substantially increase in the future. With its 
rapidly-growing populations and rising life  
expectancy, an increase in the number of  
     Deaths By Region 
Number of tobacco-related deaths in the World 
Health Organization regions, all ages, 2016



































































United States, non-Hispanic whites (2010)
    Disparity in Tobacco Deaths 
The burden of lung cancer deaths falls heaviest  
upon the least-educated


















Percentage of Tobacco Deaths  
Number of countries with percentage of deaths 
attributable to tobacco use, by WHO region,  
Males, all ages, 2016







































Male deaths Female deaths
Deaths
Percentage of total male deaths attributable to tobacco
smokers along with population aging is likely  
to make Africa suffer the most from future  
smoking-related burden. 
Consistent with lower female smoking prevalence 
in many countries, the tobacco-related burden in 
women is lower than in men globally. However, 
with recent increases in smoking prevalence 
among female adolescents in some countries,  
this pattern may not continue. 
In addition to very high-HDI countries, with current 
trends, most other countries are or will soon be 
facing substantial smoking-related burden, while 
many already have limited health resources. Even 
in very high-HDI countries, smoking prevalence 
and the related burden are now far higher among 
lower-income groups, which are more likely to 
have limited access to care  . This dynamic 
further underscores the need for effective tobacco 
control to improve health and reduce disparities  
at the population level in all countries.
     US Lung Cancer Deaths
Lung cancer is the leading cause of cancer deaths, accounting for at least one-fourth of all  
cancer deaths in both men and women in the United States








 Explore more at ta6.org/deaths
Countries with 
≥15% of  female 
deaths due to 
tobacco use,  











Tobacco-related harms reach far beyond the death and disease caused by  tobacco consumption. Put simply, 
tobacco harms the world’s sustainable  
development. The economic cost of smoking 
globally amounts to nearly 2 trillion dollars  
(in 2016 purchasing power parity) each year, 
equivalent to almost 2% of the world’s total 
economic output. The majority of the total  
economic cost of smoking is the lost  
productivity of those sickened or killed by 
tobacco. Another 30% of these costs are the 
healthcare-related expenses of treating  
smoking-attributable diseases. Notably, this 
price tag does not include other substantial 
costs, such as the costs caused by second-hand 
smoke, non-combustible tobacco products, 
the environmental and health damages from 
tobacco farming, smoking-related fire hazards, 
cigarette butt littering, and, foremost, the 
immeasurable pain and suffering of tobacco 
victims and their families.
The cost of tobacco use is rising rapidly,  
following the increase in the number of  
tobacco users in low-, medium-, and high-HDI 
countries . Given the limited resources in 
most countries, these costs represent a lost 
opportunity to instead spend these resources 
on advancing the economy through education, 
healthcare, technology, and manufacturing. 
Because most health effects of smoking lag 
smoking initiation by more than a decade, 
the societal harm of smoking will still  
inevitably increase in countries where tobacco 
consumption has risen, and even in those 
where it has only recently started to fall .
Most tobacco users become addicted as youth 
without knowing the health consequences that 
tobacco use will eventually inflict upon them in 
the future, causing a level of economic hardship 
that they would undoubtedly not have chosen 
for their families or themselves. Regardless of a 
country’s stage of economic development, the 






















Low HDI Medium HDI High HDI Very High HDI
    Number of Smokers by HDI
The number of smokers is declining only in very-high 
HDI countries; in the rest of the world, the number  
of smokers is increasing
     Smoking Prevalence and Smoking- 
Related Mortality in Jamaica
The peak in smoking-related mortality lags behind the 
peak in smoking prevalence; smoking-related mortality 
can go up even if smoking prevalence declines

























































Deaths caused by smoking
Male Female
FIND MORE ONLINE ta6.org/societal-harms
Family falls  
into povertyFORGONE INCOME 3:
Due to premature death
FORGONE INCOME 2:
Due to treatment cost  
and loss of work days
Breadwinner gets  





Higher prevalence &  
consumption level
FORGONE INCOME 1:
More money spent on tobacco:  
high opportunity cost. Less money  
spent on education, nutrition, etc.
Vicious cycle  






















     Disparities in Smoking Prevalence



















































Lowest Wealth Group Highest Wealth Group
Economic Cost of Smoking-Attributable Diseases
burden of tobacco falls disproportionately  
on the poor, and is a source of both health and  
economic disparities . The poor spend a larger 
share of their income on tobacco products, 
crowding out spending on necessities such as 
food, education, health and shelter. Additionally, 
tobacco-related illnesses contribute to cata-
strophic health expenditures that compete with 
basic needs in poor households. When a family 
breadwinner gets sick or dies prematurely due 
to tobacco use, the entire family is devastated 
and further impoverished. This cycle of tobacco 
use and poverty is vicious  and will perpetuate 
through generations without intensified tobacco 
control efforts; thus, there is a particular need for 
efforts directed toward the poor. 
The following chapters of the Atlas will focus on 
proven tobacco control strategies. The develop-
ment and implementation of these strategies 
are fundamental investments in human capital 












T o address the tobacco menace  more successfully, there have been important, over-arching global efforts to promote tobacco control. One of  
the central initiatives to situate country-level 
efforts in the global context has been the World 
Health Organization Framework Convention 
on Tobacco Control (WHO FCTC), which 
came into force in 2005 and provides a 
systematic framework of obligations and 
corresponding guidelines to reach tobacco  
control success. The ratification of this interna-
tional treaty is voluntary and draws upon the 
political commitment of signatory countries  
to develop, implement and enforce the  
interventions. As of late 2017, the treaty had  
181 Parties. For many, it provides effective  
political acceptability to implement  
politically-challenging measures.
The implementation of key tobacco control  
demand-reduction measures (e.g., tobacco  
taxation; smoke-free policies; packaging and  
labeling provisions; marketing bans; and  
cessation programs) at the highest levels of 
achievement accelerated among the WHO FCTC 
Parties between 2007 and 2014 . Effective 
implementation of these measures is significantly 
associated with lower smoking prevalence, which 
typically leads to considerable reductions in 
tobacco-related morbidity and mortality.
Global tobacco control also fits snugly into  
broader public health efforts, for example by  
constituting a major element of the United 
Nations’ efforts to address noncommunicable 
diseases (NCDs) around the world . The 2012 
Political Declaration of the High-Level Meeting 
of the United Nations General Assembly (UNGA) 
recognized the enormous health and economic 
burden of NCDs on households and nations, and 
agreed to reduce deaths from four prominent 
NCDs (i.e. cancer, diabetes, lung disease and  
cardiovascular disease) . The WHO created 
voluntary targets for prevention of  
premature deaths from these NCDs, which  
includes a 30% relative reduction in adult  
smoking prevalence .
Global tobacco control became even more  
salient through the integration of the WHO FCTC 
in the 2015 Sustainable Development Goals 
(SDGs). These goals not only reaffirmed the  
commitment of sovereign governments to fulfill  
tobacco control implementation for public 
health, but also for sustainable development. 
National planning to achieve these goals by 
2030 provides opportunities for governments to 
demonstrate that reducing tobacco use is critical 
to achieving development goals and empowers 
them to incorporate tobacco control best prac-
tices into many development-related policies, 
paving the way to a tobacco-free generation. 
Momentum is also building globally— including 
from organizations such as the World Bank— to 
use tobacco tax revenue for financing poverty 
alleviation and other development programs  
critical to many resource-poor countries . With 
the opportunity to generate significant revenue 
while reducing tobacco consumption and  
tobacco-induced health and environmental 
costs, tobacco taxation can stand out as a 
 win-win policy for development (see text below.)
GLOBAL STRATEGY
The Success Story of the Sin Tax  
Reform in the Philippines
Enacted in December 2012, the reform was anchored 
to financing the expansion of Universal Health Care 
(UHC), in addition to alternative livelihood programs 
for tobacco farmers and health promotion. More 
than 85% of the incremental revenue from excise 
on tobacco and alcohol products was dedicated 
to these programs. Smoking prevalence declined 
sharply and the increased revenue helped to nearly 
triple the number of poor people with free health 
insurance coverage in three years.
NON-COMMUNICABLE 
DISEASE TARGET
By 2030, reduce premature 
mortality from non- 
communicable diseases  
by one third
UNITED NATIONS 
Increased revenue from 
tobacco tax increases 




Ensure healthy lives and 
promote well being
UNITED NATIONS 
SPECIFIC SMOKING  
PREVALENCE TARGET
Reduce tobacco use  
prevalence 30% by 2025.  




     Tobacco Control in  
Global Development  
Tobacco control is not limited to the target 
of reducing the burden of tobacco-related 
diseases; it is an integral part of the global 
development agenda



















































































































    The Toll of NCDs on Humanity
Share of total deaths due to NCDs (%), 2016
      Progress in Tobacco Demand-
Reduction Measures 
The implementation of key tobacco control 
demand-reduction measures at the highest  
level of achievement accelerated among the  
WHO FCTC Parties between 2007 and 2014 
     Tobacco Taxes to Aid Tobacco Control  
as well as Development
The annual increase in global excise revenue by $190 billion PPP, from raising cigarette excise  
tax in each country by $1 PPP per 20-cigarette pack, could lift a quarter of the world’s  








share of deaths 
due to NCDs  
increased by 
more than half 
from 1990 to 2016
 Explore more at ta6.org/global-strategy
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Q uitting tobacco use benefits health at any age. For smokers, smoking cessation is one of the best ways to add years to their lives. The benefits 
of quitting occur almost instantly   
and most smokers want to quit smoking .  
But quitting is difficult for most smokers, and 
the majority make multiple quit attempts during 
their lifetime, during which time they are losing 
life-years. Moreover, tobacco cessation is a cost- 
effective healthcare intervention. Accordingly, 
governments and healthcare providers should 
make available more and accessible resources  
to help tobacco users stop, as enshrined in  
the WHO FCTC Article 14. However, most  
governments are failing would-be quitters .
It is important to reach young smokers with  
cessation messages and aids. The younger 
someone is when they stop smoking, the 
greater the benefit in terms of years of life saved. 
Smoking causes a decade of life lost, but quitting 
before the age of 40 can essentially return 9 of 
those years on average, because cessation by 
that age reduces a former smoker’s chance of 
death from tobacco-related illness by 90% . 
At the same time, getting adult smokers to stop 
helps population health almost immediately.
The healthcare system and healthcare workers 
should be on the frontline of tobacco cessation. 
They can reach many tobacco users directly, 
interact regularly with them particularly at key  
life moments (e.g., disease diagnosis, pregnancy, 
etc.), and are typically a trusted information 
source. Using existing health infrastructure, the 
strategy is also economical. Cessation should 
be integrated into health professionals’ work by 
training them to 1) ask individuals if they smoke 
and record this, 2) advise smokers to stop, and  
3) actively offer help for quitting. Currently, less 
than half of countries even help health workers 
to quit or integrate tobacco cessation into basic 
medical advisement, and less than a third  
mandate recording tobacco use in patient notes.  
 
Currently, there are too few examples of  
successful population-level cessation strategies. 
Governments must invest in promoting 
cessation, by developing evidence-based  
national strategies and guidelines, and allocating 
sufficient implementation resources. Govern-
ments can introduce and maintain national 
quitlines, promote and support counseling for 
quitters (including mobile phone text messaging 
services), make cessation medicines more 
accessible and affordable, and establish mass 
communication programs to promote quitting. 
In 2017, only a quarter of WHO FCTC parties had 
a clearly-identified budget for cessation, and 
less than a quarter had a free, national quitline. 
Moreover, with only a few exceptions , lower- 
HDI countries are struggling most to develop  
cessation strategies. Raising tobacco taxes pairs 
well with these efforts: higher taxes promote 
quitting, and a fraction of new tax revenue  
could support quitting programs.
QUITTING
    Declines In Risk After Quitting
Former smokers who stop smoking by about 40 years 
old reduce their risk of dying from lung cancer by 90%






























% of current smokers who intend to quit
% of current smokers who attempted to quit in past 12 months

































































Smokers Want to Quit
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Your risk of lung 
cancer falls to  
about half that of  
a smoker’s, and  
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Effects of Quitting Over Time
National quit line, and both NRT and 
some cessation services cost-covered
NRT and/or some cessation services  
(at least one of which is cost-covered)
NRT and/or some cessation services 
(neither cost-covered)
None 
Data not reported 
 HIGH ACHIEVER – LEBANON 
- Developed official cessation strategy. 
- Mandates the recording of tobacco use in medical notes.
-  Training primary healthcare workers on the strategy and to give brief cessation advice.
-  Seeking to fast-track the licensing and import of affordable cessation medications.
 Explore more at ta6.org/quitting
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W hen thinking about stopping an epidemic, tax is usually not the first thing that comes to mind. Yet perhaps the most impactful way 
to reduce tobacco use is to tax tobacco products. 
Some countries are already successfully using 
tax to reduce smoking rates, reaping significant 
and immediate health and revenue benefits. 
While there is no maximum tax level, some set 
ambitious goals, such as New Zealand’s goal to 
increase the cost of a cigarette pack to 30 New 
Zealand dollars (ca. 20 USD) through excise  
taxation. Unfortunately, most of the world,  
predominantly its poorer parts, still lags in  
implementing high tobacco taxes   .
The mechanisms behind tobacco taxation  
are simple. A sufficiently large tax increase  
will raise tobacco product prices. By observing  
smokers’ behavior, researchers have determined 
that on average a 10% increase in cigarette 
prices makes the consumption of cigarettes fall 
by between 2% and 8%. Higher tobacco prices 
are especially effective in reducing tobacco use 
in more vulnerable populations, such as youth 
and lower-income people, because those groups 
are particularly sensitive to price increases . 
Frequent, significant tax increases are especially 
needed in countries where consumer purchasing 
power is growing. When incomes rise faster than 
cigarette prices, smoking becomes more 
 affordable, encouraging consumption .  
Excise tax increases are a proven and effective 
way to make cigarettes and other tobacco  
products less affordable. 
Globally, we have yet to realize significant  
opportunities for improving health from  
tobacco taxation. For example, using only 
tobacco taxes, countries could realistically 
achieve the World Health Organization target  
of a 30% relative reduction in smoking  
prevalence by 2025 . Unfortunately, many 
governments are still reluctant to increase  
taxes, because they often rely on tobacco 
industry reports that typically suggest that any 
additional tax increase will cause declines in 
tax revenue or a massive increase in cigarette 
smuggling. Independent studies have shown 
that these claims are usually greatly  
exaggerated; new tax increases bring in  
additional revenue for the governments,  
whereas illicit trade in tobacco products can  
be controlled while keeping prices high . 
When in force, the Protocol to Eliminate Illicit 
Trade in Tobacco Products will provide power-
ful tools to combat cigarette smuggling globally.
TAXES
     Meeting the WHO 30% Prevalence 
Reduction Target Globally 
Tobacco tax increases that result in higher tobacco 
product prices are among the most effective tobacco 
control measures available










































Making cigarettes four times more costly in all countries globally 
by 2025 would reduce the world’s tobacco use prevalence from 
the current 21% to 15% in 2025. Such a drop in prevalence would 
be sufficient to reach the World Health Organization target of 
reducing tobacco use prevalence 30% by 2025. This scenario is 
attainable, but would require a 7-fold excise tax increase.
Differential Tax Treatment Can Lead  
to Product Substitution 
Cigarette and roll-your-own tobacco sales in Cyprus
















Cigarette sales Roll-your-own tobacco sales
When the 2008-2012 cigarette excise tax increases made 
cigarettes more expensive in Cyprus, some tobacco users 
quit, while others switched to relatively cheaper roll-your-own 
tobacco. Only after a substantial tax increase on roll-your-own 
tobacco had reduced the price difference between the two 
products in 2013, did the sales of both cigarettes and  
roll-your-own tobacco decline.   Read more at ta6.org/illicit-trade

























   Cigarette Prices 
Price of 20-cigarette pack of the most-sold brand in US dollars;  
adjusted for purchasing power of national currencies
      Tax increases Do Not Lead to Increased Cigarette Smuggling  
Cigarette prices vs. illicit market in the UK
    Share of the World’s Population 
Covered by Different Cigarette  
Tax Levels, 2016  





































Price per pack, inflation-adjusted Tax-paid consumption Illicit consumption
Due to periodic cigarette tax increases, the inflation-adjusted price of cigarettes in the UK increased by 63% from 
2001 to 2016, making UK cigarette prices among the highest in the world. At the same time, the illicit market 
dropped by over 70%, along with dropping tax-paid consumption.
people live in countries with no cigarette excise tax.
1 in 100
people are covered only by minimal cigarette taxes – 
i.e., total tax below 50% of the retail cigarette price.
4 in 10
While there is no maximum tax level:
people are covered by tax at or above the WHO minimum- 









 Explore more at ta6.org/taxes
Countries with  




C reating smoke-free environments is a vital tobacco control intervention and serves important purposes. First and foremost, these laws protect 
non-smokers from the harmful effects of second-
hand and even thirdhand smoke . Secondhand 
smoke has been associated with most of the 
same harmful health effects as direct smoking. 
Conversely, one study of bartenders document-
ed prompt improvements in lung function after 
indoor smoking bans were enacted. Second, 
limiting smoking in public places helps to create 
the sense that smoking is socially unacceptable 
behavior, and reinforces the idea of non-smoking 
as a societal norm. Smokers who cannot smoke 
in public are also more likely to try to quit.
At present, despite some progress  , most  
of the world’s population is currently left 
unprotected by strong smoke-free laws and 
regulations. National-level bans exist in some 
countries, such as Turkey, which passed a ban in 
2008 prohibiting tobacco use in all indoor spaces 
including bars, cafés and restaurants, sports  
stadia, and the gardens of mosques and  
hospitals. Sometimes, laws that are in place  
have been enacted locally. In New York City,  
for example, smoking is not allowed in bars, 
restaurants, clubs, public parks, city beaches,  
or even apartments in public housing projects. 
Although approximately 1.5 billion people 
around the world are now protected to some  
extent by smoking bans in public places, more 
than 80% of the world’s population is still  
vulnerable to secondhand smoke.
In many countries and cities, smoking in many 
public places (e.g., airports) is only allowed in 
specially designated smoking rooms. Such  
partial bans are often ineffective. Ventilation for 
such smoking rooms does not remove all the 
smoke, so leakage occurs around doors and 
windows. Additionally, smoking is still preserved 
as a social norm, removing a major motivating 
factor for smokers to quit .
Governments must be comprehensive and 
forceful in their smoke-free policies. For example, 
some jurisdictions have begun to include water 
pipes in their ban, or have at least implemented 
partial bans (e.g., the United Arab Emirates). 
E-cigarette public bans (including New York City) 
— not without controversy — have also become 
more common around the globe.
SMOKE-FREE
 Progress in Smoke-free Legislation  
2007-2016
FIND MORE ONLINE ta6.org/smoke-free
Current global population: 7.6 billion
What is thirdhand smoke?
It refers to residues of 
tobacco and tobacco  
byproducts that solidify  
and form in carpets,  
drapes, and other  
surfaces in rooms where smoking  
occurred. These residues contain many of the 







































































Designated smoking areas leak smoke 
and make public smoking acceptable
Smoke-free Environments
Countries with all public places completely smoke-free (or at least 90% of  
the population covered by complete subnational smoke-free legislation)
  Prohibit smoking in all indoor public places,  
indoor workplaces, and public transport,  
without exception (including the elimination  
of designated smoking areas). 
  Policies should be comprehensive to include  
products such as water pipes and cigars that  
sometimes receive special treatment.  
  Monitor compliance and strengthen enforcement. 
Consider including administrative sanctions for  
establishments not in compliance (such as  
revocation of licenses).
  Expand the list of outdoor (e.g., stadia) and  
semi-outdoor places (e.g., covered patios)  
where smoking is prohibited. 
Smoking outlawed in tram  
stations in Turkey
GOOD PRACTICE BEST PRACTICES BAD PRACTICE
Highest achieving 
countries
 Explore more at ta6.org/smoke-free
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A s individuals’ knowledge and belief in the toxic health effects of tobacco use grow, the likelihood of using tobacco decreases and their support for  
protective policies increases. Mass media give us 
the opportunity to efficiently persuade large  
populations about the urgent need for action.  
Using media to inspire individuals to quit tobacco 
or persuade them not to start using it, and societies 
to take up policies for a tobacco-free future is a 
critical part of the tobacco control toolbox. 
Media campaigns are embedded both in both WHO 
FCTC Article 12 and the WHO MPOWER package 
– “W” for Warning. Successful campaigns change 
individual behavior, shift broader social norms, and 
build popular support for tobacco control policies. 
Moreover, research in countries across the Human 
Development Index (HDI) demonstrates that cam-
paigns can be cost-effective — just a few cents per 
quit attempt in some countries  .
Two essential components of successful campaigns 
are effective messaging and delivery. Research 
consistently demonstrates the effectiveness of 
campaigns that challenge audiences to deal with the 
specific negative impacts of smoking — e.g., cancer, 
blindness and lung disease. Some examples are 
victims’ real-world testimonials or graphic  
depictions of damage. 
Best-practice campaigns use behavioral research to 
test messages with intended audiences— e.g., male 
smokers— to ensure they are effective and culturally 
relevant. In lower-HDI countries, costly research can 
be avoided by adapting campaigns from other areas 
that have a strong evidence of success and target 
similar populations— e.g., compelling graphic  
images have been found to have wide application 
across many cultures. Supportive campaign 
messages such as highlighting stories of happy 
ex-smokers may also reinforce smokers’ belief they 
can successfully quit. A poorly-messaged campaign 
can have little or no impact. Finally, it is critical to 
rigorously evaluate a campaign’s impact.
Underinvestment in media delivery and planning  
is a frequent failing of tobacco control programs.  
Successful use of mass media requires sustained 
campaigns with broad population reach. This 
includes keeping campaigns “on the air” most 
months of the year. The most successful campaigns 
use a mix of media channels— usually television 
and radio due to their high reach and proven impact 
—with social and digital media as an emerging 
tool in many key populations  . Sustained media 
delivery with high reach, such as extended national 
television campaigns, can be expensive. Many 
countries have implemented innovative policies to 
ensure that their tobacco control media campaigns 
receive placements. These range from health pro-
motion foundations that utilize tobacco 
taxes to fund campaigns to legislation that  
mandates television and radio channels dedicate  
a portion of prime-time programming to public 
health messages .
Recent evidence shows that campaigns can use 
social media to mobilize large populations to 
advocate for tobacco control policies. In Vietnam, 
small-dollar social media ads on Facebook were 
used to generate significant public discourse  
online and offline around pending legislation, 
which ultimately passed.
MEDIA CAMPAIGNS
FIND MORE ONLINE ta6.org/media-campaigns
Mass Media and Quitting  
Mass media campaigns have prompted 
increases in quit line calls and turned the  
tide of public support for novel policies
The national "Sponge" 
mass media campaign 
in Senegal prompted 
a near 600% increase 
in calls to the quit line, 
compared to the  
pre-campaign period. 
      Impressive return on  
investment for media  
campaigns in India  



































Mass Media Best Practice Countries 
High- and low-HDI countries have mounted gold-standard media campaigns,  
but globally media campaigns remain underutilized
Australia’s long-running efforts using mass media 
have helped drive down tobacco use to record lows 
among adults and youth. The country’s sustained 
effort uses television, radio and digital platforms  
to achieve greater population reach and has  
produced graphic advertising that has been  
adapted around the world.
Turkey’s comprehensive tobacco control legislation 
requires TV and radio stations to air 90 minutes  
of Ministry of Health ads each month, including  
30 minutes in peak hours. Using this innovative  
strategy, Turkey has mounted numerous anti- 
tobacco campaigns each year, reaching most  
citizens and driving millions to quit smoking.
Anti-tobacco education initiatives that are based 
within schools have been found to be largely  
ineffectual. The most impactful campaigns have 
been shown to be those using mass media to  
target large segments of the population, with 
hard-hitting messages on the harms of tobacco  
for most months of the year.
GOOD PRACTICE CUTTING EDGE PRACTICEBAD PRACTICE
Campaign conducted with at least  
seven appropriate characteristics  
including airing on television  
and/or radio
Campaign conducted with five to  
six appropriate characteristics, or 
with seven characteristics excluding 
airing on television and/or radio
Campaign conducted with one to 
four appropriate characteristics
No national campaign implemented 
between July 2014 and June 2016 
with duration of at least three weeks
Data not reported 
 Explore more at ta6.org/media-campaigns
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The complexities of tobacco control interventions necessitate collabo- ration among a multitude of actors. Challenged by systematic tobacco 
industry interference, a wide range of local, 
regional and international civil society part-
ners, international health and development 
governmental organizations, local and 
national government ministries, and private 
businesses have partnered together to 
confront and counter the tobacco industry. 
The results to date have been a mix of many 
different types of partnerships and a growing 
body of evidence of what works and  
what does not.
For 16 years, Vital Strategies (VS) and the 
American Cancer Society (ACS) have worked 
together to produce this important resource, 
The Tobacco Atlas, for the public health  
community. In hindsight, the fruits of this  
enduring partnership can be largely  
attributed to an alignment of interests,  
skills and needs between the two  
organizations. More specifically, they both:
•  Are passionate about tobacco control  
and see the value in the resource they  
are producing;
•  Bring different yet complementary skills  
and expertise to the partnership;  
•  Have strong subject matter expertise  
and similar enough views on issues that 
allow them to avoid major differences  
of opinion or find acceptable and  
appropriate compromises;  
PARTNERSHIPS
FIND MORE ONLINE ta6.org/partnerships
Brazil – Partnering to Counter 
Tobacco Industry Tactics
In Brazil, the tobacco industry has systematically interfered 
with tobacco control legislation, most recently halting the 
progress of Brazil’s ban on tobacco additives. To counter 
this interference, prominent health NGOs allied under the 
auspices of the national tobacco control coalition worked 
with government agencies and unlikely partners, like 
tobacco farmer organizations, to engage in sustained and 
strategic advocacy efforts. They also received instrumental 
international support from the Bloomberg Initiative to 
Reduce Tobacco Use partners.
•  Bring resources to the partnership making 
neither wholly dependent on the other; 
•  Like, trust, and appreciate each other; and
•  Can make key decisions together  
and follow timelines effectively.
A recent outcome from this successful  
partnership is that the two organizations 
have banded together again to support the 
global cancer community in their efforts 
to raise the profile of tobacco taxation as 
a cancer prevention strategy through the 
Prevent20 Coalition .  
Among other things, ACS and VS plan to 
monitor progress and outcomes to share 
successes and lessons learned from the 
partnership and encourage other risk factor 
and disease-focused groups to emulate 
achievements for further impact.
Each day there are new opportunities to 
innovate as a tobacco control community 
that require less-traditional partnerships  
to address important evolving issues.  
Establishing stronger linkages among the 
tobacco control, global health and  
development communities has been  
recognized as an important priority.  
Regulating new tobacco products also  
presents a complex set of challenges that  





























Vital Strategies and the  
American Cancer Society –  
a Long Partnership History 
The American Cancer Society, via its Research 
and Global Cancer Control departments, has 
been partnering with Vital Strategies’ Policy, 
Advocacy and Communications team for 
many years. Their respective subject matter 
expertise has allowed the creation of a unique 
research-to-action tool, bringing compelling 
evidence into the hands of advocates and 
policy-makers around the world. 





TOBACCO CONTROL POLICY ADVOCACY 
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Prevent20 Members and Friends
Working Together for Better Research
FCTC Article 5.2a Collaboration
These partners working closely with stakeholders across WHO FCTC parties, particularly tobacco control focal points and members of tobacco control intra- 




observer to the 
FCTC and longtime 
global advocate  
of tobacco control







The FCTC Secretariat 
helps Parties to enact 
the treaty's provisions
This UN organization 
is helping to make the 
strong link between 
tobacco control  
and development
Report on the  
Implementation of  





 Explore more at ta6.org/partnerships
 Learn more at wecanprevent20.org
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REGULATING NOVEL PRODUCTS
E-cigarettes, the predominant type of electronic nicotine delivery system (ENDS), were originally designed to  
reduce smoking by replacing tobacco  
cigarettes, and there is limited but growing  
evidence that they are helping some smokers 
to transition away from combusted tobacco. 
The preponderance of available evidence 
suggests that using current-generation  
e-cigarettes is substantially less harmful than 
using tobacco cigarettes. However, there are 
lingering concerns about the harm from using 
e-cigarettes, particularly the uncertain long-
term effects of nicotine use in the absence 
of combusted tobacco, and the interactions 
of heated e-liquid with sensitive lung tissue. 
There are also questions about whether 
e-cigarettes might pull ex-smokers back to 
using nicotine, and some argue that a causal 
“gateway effect” exists wherein youths begin 
to smoke tobacco cigarettes due to their 
exposure to e-cigarettes. 
E-cigarettes present several regulatory 
challenges, and policymakers and  
governments continue to struggle with how 
to regulate them effectively. The most basic 
issue is whether these novel nicotine products 
should be given market access at all. At least 
36 countries ban e-cigarette sales altogether, 
or permit device sales but ban the sale of  
nicotine e-liquid. This approach is under-
standable for nations with very low smoking 
prevalence where introducing a new nicotine 
product might undermine tobacco control 
efforts. Most governments are trying a variety 
of other approaches to gatekeeping market 
access, ranging from permissive (e.g., similar 
 to existing tobacco products) to more  
restrictive (e.g., requiring authorization from 
health authorities before entry into the  
market and on an ongoing basis) .
Beyond market access, there are several  
other policies to consider. First, should  
existing tobacco cigarette regulations—  
e.g. excise taxes, public use bans, and market-
ing restrictions —be applied to e-cigarettes, 
and to what degree? Consider that many 
e-cigarette advertisements are blatantly 
directed at youth, recalling cigarette ads in 
the recent past  . Also, many countries have 
product safety regulations pertaining to  
e-liquid contents, child-safe packaging, 
nicotine quality and concentration, flavors, 
and other ingredients. Lastly, policymakers 
will need to consider what regulations should 
apply to “heat-not-burn” products that heat 
processed tobacco in a controlled fashion 
rather than combusting it . They are likely  
to be more harmful than e-cigarettes because 
they contain tobacco, and the early evidence 
shows that they contain considerably higher 
levels of toxins than do e-cigarettes. There will 
not be much time to decide: heat-not-burn  
is already rapidly gaining market share in 
Japan, and has been introduced in more 
than 25 countries.
Problematic Ads
“Welcome Back” suggests an appeal to ex-smokers 
Appeals to ex-smokers
FIND MORE ONLINE ta6.org/regulating-novel-products
Appeals to youth






































Cartridge that contains 
liquid nicotine and/or 
other ingredients
Sensor to detect  
when a smoker puffs
Microprocessor  






   Market Access Map
Uncertainty and controversy have contributed to wide variation  
in e-cigarette market access across the world
     Slick retailing
Philip Morris is marketing their 
novel IQOS product in trendy 
stores with eager customer  
service representatives,  
resembling Apple Stores.
Extension of Tobacco Control Policies  
Policy Integration Differentiation Concerns
Smoking 
Bans
Extend existing bans  
to ENDS
ENDS allowed in public 
and private spaces
• Involuntary exposure to nicotine
• Nuisance
•  Undermine cessation effect of 
smoking bans
Ad Bans Extend all ad  restrictions to ENDS
More permissive 
approach to placement 
and content of ENDS ads
• Youth and nonsmoker targeting
• Sneaky smoking promotion
Warning 
Labels
Require warning label 
focused on toxicity
Focus on addiction,  
uncertainities, explosions
•  Blurring line between harms of ENDS 
and greater harms of smoking
Taxes Same taxes as other  tobacco produts
Lower taxes than other 
tobacco products
• High enough price to reduce youth initiation
• Price reflecting harm
E-cigarette Device Types
E-cigarette and ENDS designs have evolved 
rapidly over the past decade
E-cigarettes are mainly  
either cig-a-like, tank  
systems, or personal 
vaporizer (PV).
Tank style and PV products 
are refillable with e-liquid. 





Bans include de jure bans of 
e-cigarettes or nicotine e-liquid, 
as well as de facto bans where 
government  approval is required 
but has not been granted to date.
E-cigarettes banned
E-cigarettes containing  
nicotine banned
Market Authorization Required
Sales Permitted and Regulated
Unclear or No Explicit Policy
 Explore more at ta6.org/regulating-novel-products
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W hen governments imple-ment effective tobacco control policies, tobacco smoking declines. More 
quitting and less initiation of tobacco use 
contribute to greater individual and  
societal well-being. Successful tobacco 
control also hurts the financial health  
of tobacco companies. Consequently,  
tobacco companies act in their own  
interest, for example, by aggressively  
lobbying and litigating against govern-
ment tobacco control policies, among 
other tactics.
In its zeal to promote tobacco use, the 
tobacco industry regularly perpetrates 
unethical, and often unlawful, interference 
with life-saving tobacco control policies. 
Although tobacco companies compete 
for market share, they often collude to 
counter government tobacco control ef-
forts, or support front groups to do the job 
for them. Other strategies involve openly 
misrepresenting scientific evidence to 
confuse the public .  
Limiting this tobacco industry interference 
is possible. The WHO FCTC Article 5.3 
guidelines identify specific limitations to 
the industry’s involvement in policy- 
making, and outline strategies to limit the 
industry’s participation and misconduct, 
including paying close attention to the 
industry’s actions. Industry monitoring 
programs are in place in many countries 
(including Brazil, South Africa, Sri Lanka, 
and the UK, among others). However, 
many governments do not report results 
from these monitoring efforts to the FCTC 
Secretariat as required by the treaty, nor 
is there sufficient effort yet to share this 
information among governments.  
Resources to address industry interference 
are also frequently lacking. International 
donors, such as the Bloomberg Philan-
thropies, have provided helpful funds for 
countries that lack capacity or resources 
to face multi-billion dollar companies  
in courts. Still, more stable funding  
mechanisms for legal support to govern- 
ments are needed. In many places,  
directing funds from increases in tobacco 









LOBBYING AND HIJACKING 
LEGISLATIVE PROCESSES









































The tobacco industry has long denied  
established scientific knowledge and  
popularized falsehoods, from deliberately 
clouding the links between smoking and lung 
cancer decades ago to misrepresenting the 
effects of plain packaging regulations now.  
In the US, they effectively utilized a small  
number of scientists to sow doubt about the 
hazards of smoking among policymakers  
and the public. The industry has promoted  
general mistrust toward science —  
a phenomenon that cripples global progress.
MEDIA MANIPULATION
The industry uses media to influence attitudes 
on a massive scale, often without disclosing 
funding, sponsorship, or authorship of content 
presented as objective “news”. The industry  
secures content consistent with their interests 
by using advertising dollars to control media 
messages, by manufacturing information  
sources, or by ghostwriting pro-tobacco  
content. These messages underplay the  
benefits of proposed policies, exaggerate their 
costs, and overstate the industry’s contribution 
to the economy and government revenue. 
PUBLIC RELATIONS
Tobacco companies use philanthropy to link 
their public image with positive causes and 
build support among more credible groups, 
including local communities, NGOs, artistic/
athletic organizations, academic institutions,  
or even governments and development  
agencies. When new tobacco control policies 
are on the agenda, the image of a good  
“corporate citizen” redirects attention away  
from the dire consequences of smoking. 
USURPING THE AGENDA
The industry declares itself “part of the solution”, 
but its ineffective voluntary measures cloud 
the regulatory space, often preventing or 
delaying implementation of effective policies. 
The industry previously launched campaigns 
to supposedly prevent youth smoking, which 
superficially appeared to warn against smoking, 
but were ultimately found to encourage kids to 
start smoking. The industry now proposes to 
“solve” challenges with illicit cigarettes via an 
industry-controlled tracking system, shifting 
power from governments to the industry.  
The industry also demands a voice in harm- 
reduction policy-making by claiming a  
commitment to producing less-harmful  
products. For example, Philip Morris  
International recently created a Foundation  
for a Smoke-Free World while continuing to 
actively promote their same lethal products.
CREATING ILLUSION OF SUPPORT
Front groups appear to serve a public cause 
but actually serve as the voice of the tobacco 
industry. These groups amplify industry  
messages by disguising the messenger,  
frequently giving policymakers the illusion  
of a broader coalition. The tobacco industry 
funds groups ranging from restaurant  
associations opposed to smoke-free laws,  
to large international think tanks against tax 
hikes. These groups repeatedly fail to disclose  
their funding and sponsorship, deceiving  
policymakers and the public about their  
true origin and intentions. 
LOBBYING AND HIJACKING  
LEGISLATIVE PROCESSES 
The industry uses political contributions and 
front groups to gain access to policymakers,  
and does not hesitate to provide ready-to- 
use legislative proposals. Governments 
determined to control tobacco use are being 
intimidated by messages misusing scientific  
evidence and misrepresenting effects of 
proposed regulations. In a particularly egregious 
example in 2017, the UK Serious Fraud Office 
opened an investigation into British American 
Tobacco involvement in bribing policymakers 
in at least four African countries: Burundi, 
Comoros, Kenya, and Rwanda.
EVASION
Once tobacco control legislation is passed,  
the industry often decides to deliberately  
circumvent or disobey the rules. One of the 
most damaging is the industry’s involvement  
in the illicit cigarette trade, dodging tobacco 
taxes and supplying large quantities of their 
products through illegal channels. 
LITIGATION
Litigation has become one of the industry’s 
deadliest weapons. The battles are fought at  
every level from domestic courts to international 
arbitration, where the vast legal resources of the 
large tobacco firms are commonly pitted against 
the often-limited legal resources of low- and 
medium-HDI countries. When the companies 
cannot directly bring a case, they use countries 
with lower public-policy standards to file formal 
disputes for them. The industry has been 
actively litigating tobacco control regulations 
in dozens of countries, while litigation threats 
“chill” similar measures in other countries, such 
as plain-packaging laws in New Zealand.
USURPING  
THE AGENDA
    Industry Interference
The tobacco industry deploys an array of strategies 
to undermine tobacco control efforts 
 Read more at ta6.org/illicit-trade






Tobacco control faces a most daunting foe in an enormous, highly-profitable, and politically well-connected tobacco  industry driven to expand its customer 
base to maximize profits. However, there are  
proactive steps that the tobacco control  
community can take to counter the industry  
and maximize public health goals. 
Preparation. One of the best strategies is to plan 
for the industry’s inevitable pushback against any 
tobacco control effort that is likely to reduce their 
customer base — i.e., think before the implemen-
tation of an intervention. The tobacco industry 
typically employs the same set of strategies to fight 
against tobacco control efforts, no matter the time 
or place. For example, the industry continues to 
litigate against tobacco control policies in courts 
across the world, including claims that measures 
violate commitments to international economic 
agreements . Anticipating that the industry would 
challenge their plain, standardized tobacco pack-
aging initiative, Australia’s health ministry worked 
in advance with its trade and foreign affairs coun-
terparts to develop policy that would withstand 
scrutiny in trade dispute settlement, including  
in the World Trade Organization .  
Capacity. Effective tobacco control needs a variety 
of established professional skill sets, including 
economics, law, medicine, public health, social 
science, and communications to successfully 
execute policies and programs. For the countries 
lower on the Human Development Index, this will 
almost certainly mean some resource assistance, 
peer guidance, and targeted educational  
development from external supporters. The  
tobacco control community must escalate the  
engagement of appropriate professionals to  
outpace the industry’s own hired experts.
Accountability. Governments must be  
accountable to their citizens, which includes  
ensuring overall societal well-being. Actively  
pursuing the straightforward obligations and 
recommendations of the WHO FCTC— including 
allocating sufficient resources to these efforts—  
will contribute to improved tobacco control,  
and therefore, greater societal well-being. The 
return on investment from tobacco control in 
lower health costs and increased productivity is 
enormous. Reliable and consistent measuring of 
progress can help to increase accountability.
 
Transparency. With near-constant pressure from 
the tobacco industry, governments must imple-
ment policies consistent with WHO FCTC Article 5.3 
to make any interactions with the tobacco industry 
completely transparent— a crucial component 
of accountability. Moreover, the tobacco industry 
must have no place in shaping health policy or any 
policies that are likely to have health effects. 
Multi-sectoral approach. As enshrined in WHO 
FCTC Article 5.2(a), for tobacco control to work 
more effectively, different sectors must work 
together. In the case of tobacco taxation, finance 
ministries must work with health counterparts to 
better understand how tax policy can maximize 
both revenues and health impacts. Health  
ministries are generally the natural tobacco control 
focal point, but they must understand their peer 
departments, and work to educate and empower 
them to vigorously promote tobacco control.  
Beyond government, civil society can help to  
pressure governments for better tobacco control 
and provide independent expertise, while the 
research sector can help to build tobacco  
control’s evidence base.




































   Tobacco Control and Litigation
Recent or current litigation against tobacco control efforts  
and/or litigation against the tobacco industry
The tobacco industry continues to aggressively litigate against tobacco control policies, but governments, the public health community and individuals have also been successfully using 
the courts to fight the tobacco industry’s deadly ways.
The World Trade Organization and Plain, Standardized Packaging
The WTO has become an important venue in which economic and health policies intersect
VENUE SHOPPING
The tobacco industry attempts to stop effective  
policies by any means necessary. Accordingly, they 
“shop” for the most favorable venue to do their bid-
ding. Governments and tobacco control proponents 
need to understand these venues given the local 
context to neutralize the tobacco industry.
Venues include: legislatures; the courts (at all levels:  
municipal (e.g., local smoke-free ordinances), state/
regional (e.g., taxation in some countries), and national 
(almost anything!)); and international bodies such  
as the World Trade Organization, trade agreements  
and bilateral investment treaties. 
Government or individual
 suing tobacco industry 
Tobacco industry or its proxy 
suing government over  
tobacco control measure(s)
Both types of litigation
 Explore more at ta6.org/countering-the-industry
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Global tobacco consumption is slowing. This is largely due to many countries implementing successful tobacco control programs. Slowly, the tobacco 
control community is “normalizing” its  
interventions. For example, a decade ago, just  
10 countries had comprehensive smoke-free 
policies whereas today it is 55, with 23 more 
almost there. For those fortunate enough to live 
in smoke-free environments, it is thanks to these 
efforts that encountering smoking in a restaurant 
today feels so jarring. Once a society has adjusted 
to a smoke-free norm, it becomes difficult to 
understand why smoking was ever tolerated.  
But more work remains to be done.
Many tobacco control proponents aspire to a so-
called “end game” for tobacco, and such visions 
vary considerably, from complete eradication of 
tobacco use to declines in prevalence to 5% or 
less.  While it is important to aspire, we emphasize 
that vigorous implementation and enforcement 
of the proven strategies would undoubtedly drive 
tobacco prevalence down significantly and just as 
importantly keep low prevalence low. The largest 
obstacle in many countries remains a lack of will. 
Some government officials are still unwilling to 
follow through on commitments to the WHO FCTC, 
and more broadly, to commit sufficient  
resources to promoting societal well-being through 
comprehensive tobacco control. Though there 
were small victories at the Seventh Conference of 
Parties of the WHO FCTC in late 2016, there were 
also disturbing signs of governments indifferent 
to tobacco control. Even worse, some official 
delegates promoted messages remarkably similar 
to those of the tobacco industry. These dynamics 
reinforce that the industry remains a powerful and 
ubiquitous force globally and must not be underes-
timated. However, an emerging global orientation 
toward preventing non-communicable diseases, 
and tobacco control’s increasing place on the  
development agenda, are helping to challenge  
the industry’s power. 
There is considerable discussion in the public 
health community about the role of potentially less 
harmful tobacco products. This issue is complex. 
We implore readers to be open-minded but also 
skeptical, and to always turn to science – tobacco 
control must be grounded in facts. There may be 
no one-size-fits-all solution to this new challenge, 
but we must work together as a public health 
community, find or rigorously generate the neces-
sary evidence, interpret it thoughtfully, and avoid 
dogmatism that serves to divide and potentially 
obfuscate important truths. While we must address 
new developments, we also cannot let them  
distract from the key tasks at hand, particularly  
implementing evidence-based measures such as 
high excise taxes on cigarettes. New approaches 
to reducing tobacco-related disease will almost 
certainly work better in concert with proven  
measures to motivate quitting and discourage 
initiation. Moreover, there is no substitute for the 
weight of government action when it comes to 
implementing these proven measures.
As a modest start, we can set our sights on the 
established goal of a 30% relative reduction in prev-
alence by 2025 (from a 2010 baseline) with far more 
ambitious goals immediately thereafter. But gov-
ernments must make a larger effort to implement 
these interventions and proponents working within 
government must raise their voices for change. And 
those outside of government, including civil society 
and researchers, must pressure governments to 
redouble their efforts, and provide assistance 
necessary to realizing these goals. We hope you will 
commit seriously to be part of this effort to save 
millions of lives from the scourge of tobacco use. 
OPTIMISM



























Please join us at www.tobaccoatlas.org,  
where you’ll find additional exciting  
content and the most up-to-date data  
and developments as we work toward  
a tobacco-free future.
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Tobacco Control Policy Implementation 
Average performance across five major tobacco control policies:  
smoke-free, warning labels, cessation, marketing bans and taxes








ing prevalence of 
a tobacco control 
high-performer in 
each WHO region – 
Australia, Denmark, 
Iran, Nepal, Uganda 
and Uruguay.
 Explore more at ta6.org/optimism
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abdomen, health effects on, 24
ACS. See American Cancer Society
ACT Health Promotion (Brazil), 44
additives, prohibitions on, 11, 16
adolescents, smoking prevalence of, 20. See also youth
adults: males, smoking prevalence by, 21; secondhand smoking illnesses in, 22
advertising bans, 11, 19; countries implementing, 35; ENDS and, 47
Africa: tobacco affordability in, 28;  
              tuberculosis in, 26. See also sub-Saharan Africa
AIDS, tobacco use and, 26
alcohol abuse, tobacco use and, 26
American Cancer Society, 44, 45
anti-smoking agenda, tobacco industry’s usurping of, 49
anxiety disorders, tobacco use and, 26
Argentina, quitting in, 36
asthma, secondhand smoking and, 22
atherosclerosis, secondhand smoking and, 22
attention deficit disorder, tobacco use and, 26
Australia: countering tobacco industry in, 50;  
                    graphic advertising in, 43;  
                    mass media campaigns in, 43;  
                    plain packaging law in, 19
Bangladesh: quitting in, 36;  
   smoking prevalence in, by wealth groups, 31
behavioral research, 42
bilateral investment treaties, 51
bipolar illness, tobacco use and, 26
bladder cancer, quitting and, 37
Bloomberg Initiative to Reduce Tobacco Use, 44
Bloomberg Philanthropies, 48
brain, health effects on, 24
brands, introduction of, freeze on, 16
Brazil: menthol ban in, 16;  
              partnership in, 44;  
              quitting in, 36;  
              tobacco industry monitoring in, 48
breast cancer: deaths from, 29; secondhand smoking and, 22
bribes, tobacco industry’s use of, 49
British American Tobacco, 16, 17, 49
bronchus cancer, deaths from, 25
Burkina Faso, smoking prevalence in, by wealth groups, 31
Burundi, tobacco industry’s bribes in, 49
California, mental disorders and tobacco-related illness in, 26
Cambodia, smoking prevalence in, by wealth groups, 31
Cameroon, quitting in, 36
Canada: cigarette standardization and, 19;  
                  menthol bans in, 16
cancer. See individual types of cancer 
cervical cancer, quitting and, 37
cessation: medicines for, 36; programs for, 10, 35; WHO Cessation Index, 37
chest, health effects on, 24
child labor, 14
children: marketing to, 18; secondhand smoking illnesses in, 22. See also youth
China: quitting in, 36; secondhand smoke in, 22; tobacco production in, 14
chronic obstructive pulmonary disease, 24; deaths from, 25; secondhand smoking 
and, 22
chronic respiratory symptoms, secondhand smoking and, 22
cig-a-like, 47
cigarettes: deaths from, 28; excise taxes on, 17; illicit, 17;  
      market position of, solidified, 16; mechanized manufacture of, 14;  
      pre-market scrutiny of, 16; prices of, 39; smuggling of, 17. See also tobacco
circulatory system, health effects on, 24
colorectal cancer, deaths from, 29
Columbus, Christopher, 14
comorbidities, 10, 26–27
Comoros, tobacco industry’s bribes in, 49
Congo, smoking prevalence in, 21
consumption, change in, by region, 21










coronary heart disease: quitting and, 37; 
                                                 secondhand smoking and, 22
corporate social responsibility campaigns, 18
Costa Rica, quitting in, 36
Cyprus: cigarette manufacturing in, 17;  
                 differential tax treatment in, 38
DALYs. See disability-adjusted life years
deaths: from secondhand smoke, 22; tobacco use and, by WHO region, 28
Democratic Republic of Congo, smoking prevalence in, by wealth groups, 31
de-nicotinization, mandatory, 17
desertification, 15
diabetes mellitus, deaths from, 25
disability-adjusted life years, percent of, tobacco use and, 25
disposal, regulation of, 11
Dominican Republic, smoking prevalence in, by wealth groups, 31
ears, health effects on, 24
e-cigarettes: advertisements for, 19; challenges of, 46;  
      device types, 47; outcomes of, 46; public bans on, 40;  
      regulation of, 46; worldwide market access to, 47
economic disparities, tobacco and, 30–31
Egypt, quitting in, 36
ENDS (electronic nicotine delivery systems), 47
environmental degradation, 14, 15
environmental devastation, tobacco use and, 11
esophageal cancer, quitting and, 37
Ethiopia, menthol ban in, 16
Europe, secondhand smoke in, 23
European Union: menthol ban in, 16;  
            secondhand smoke in, 22
evasion, tobacco industry’s practice of, 48, 49
excise taxes, 11, 17. See also taxation; taxes
ex-smokers, appeals to, 46 
eyes, health effects on, 24
FCTC. See Framework Convention on Tobacco Control
feet, health effects on, 24
females: deaths of, smoking and, 29; lung cancer among, 24;  
      reproductive health and, 24; secondhand smoke and, 22
flavorings, ban on, 11, 16
Food and Drug Administration (US), 16, 17
Foundation for a Smoke-Free World (Philip Morris), 49
Framework Convention on Tobacco Control (WHO), 10, 34, 35, 36, 45, 52;  
      advertising bans and, 19; cessation and, 36; governments and, 50, 52,  
      marketing policies, 18; media companies and, 42; tobacco control  
      measures and, 35; tobacco farming and, 14; tobacco industry and, 48
free trade zone cigarette factories, 17
front groups, tobacco industry’s use of, 49
Ghana, smoking prevalence in, by wealth groups, 31
global strategy, tobacco control, 34–35
governments: accountability of, 50; transparency of, 50
graphic advertisements, 43, 51
Greece: quitting in, 36;  
                 secondhand smoke in, 22
hair, health effects on, 24
hands, health effects on, 24
HDI. See Human Development Index
health effects, 10; graphic depictions of, 18, 42
heart disease, 24
heat-not-burn products, regulation of, 46
HIV, tobacco use and, 26
Human Development Index, 10
hypertensive heart disease, 24
ila (International Institute for Legislative Affairs; Kenya), 45
illicit cigarettes, 17, 38, 39, 49 
India: media campaigns in, return on investment for, 42;  







             smoking prevalence in, by wealth groups, 31
Indonesia: former tobacco farmers in, 14, 15;  
                       quitting in, 36;  
                       secondhand smoking in, 22, 23;  
                       smallholder profits in, 14;  
                       smoking prevalence in, by wealth groups, 31
indoor smoking bans, 11, 40
infants, risk to, 24
ingredients, disclosure of, 16
internet marketing, ban on, 18
intestinal ischemia, 24
IQOS (Philip Morris), 47
ischemic heart disease, deaths from, 25
Jamaica: smoking prevalence in, 30;  
                    smoking-related mortality in, 30
Japan, heat-not-burn products in, 46
Kazakhstan, quitting in, 36
Kenya: alternatives in, for tobacco farmers, 14;  
               quitting in, 36;  
               smallholder profits in, 14;  
               tobacco industry’s bribes in, 49
larynx, cancer of, secondhand smoking and, 22
legislative processes, tobacco industry’s hijacking of, 48, 49, 50
legs, health effects on, 24
Lesotho, smoking prevalence in, 21
life, lost years of, 24
litigation: tobacco control and, 51; tobacco industry and, 51
liver, health effects on, 24
liver cancer, deaths from, 29
lobbying, tobacco industry’s use of, 48, 49
low birth weight, secondhand smoking and, 22
lower-income groups, taxation policies and, 38
lower respiratory infections: deaths from, 25; secondhand smoking and, 22
low-tar cigarettes, 24
lung cancer, 24; deaths from, 25, 28, 29, 36; quitting and, 37;  
      secondhand smoke and, 22
Malawi: environmental degradation in, 15;  
                 smallholder profits in, 14
Malaysia: factory closing in, 17;  
                    quitting in, 36
males: deaths of, smoking and, 28; global distribution of smokers, 21;  
      lung cancer among, 24; reproductive health, effects on, 24;  
      secondhand smoke and, 22; smoking prevalence of, 20
marketing: bans on, 10, 11; regulation of, 11; to vulnerable groups, 10
MarkTen e-cigarettes (Philip Morris), marketing of, 19
Mauritania, smoking prevalence in, 21
McGill University, 45
media, tobacco industry’s manipulation of, 49
media campaigns, for tobacco control and cessation, 10, 42–43; best-practices  
      countries for, 43; elements of, 42; frequency of, 42; messaging in, importance of, 42; 
      social media and, 42; underinvestment in, 42; underutilization of, 43
mental illness, tobacco use and, 26, 27
menthol, banning, 16
Mexico: quitting in, 36;  
                 secondhand smoke exposure in , 23
middle-ear disease, secondhand smoking and, 22
mouth: health effects on, 24; cancer of, quitting and, 37
MPOWER (WHO), 42
nasal irritation, secondhand smoking and, 22
nasal sinus, cancer of, secondhand smoking and, 22
NCDs. See non-communicable diseases
Nepal, smoking prevalence in, by wealth groups, 31
New York City: e-cigarette public bans in, 40;  
      smoke-free legislation in, 40
New Zealand: plain-packaging laws in, 49;  
     taxation in, 38;  
     tobacco industry litigation in, 49
nicotine: absorption of, 16; levels of, lowering, 16, 17; e-liquid, 46
Niger, smoking prevalence in, 21
Nigeria, quitting in, 36
non-combustible products, 10
non-communicable diseases: prevention of, 52; UN targets for, 34
nonsmokers, protection of, 11
nose, health effects on, 24
novel products, regulation of, 46–47. See also e-cigarettes 
ovarian cancer, deaths from, 29
packaging: attractiveness of, 18; plain and standardized, 11, 18, 19
Pakistan: quitting in, 36;  
                    secondhand smoking in, 22, 23;  
                    smoking prevalence in, by wealth groups, 31
Panama, quitting in, 36
pancreatic cancer: deaths from, by sex, 29; quitting and, 37
partnerships, 44–45
pharynx, cancer of, secondhand smoking and, 22
Philip Morris, 19, 47, 49
Philippines: quitting in, 36;  
 secondhand smoke exposure in, 23;  
 sin tax reform in, 34;  
 smallholder profits in, 14
point-of-purchase advertising, regulation of, 11, ban on, 18
Poland, quitting in, 36
political contributions, tobacco industry’s use of, 49
poverty, cycle of, and tobacco, 30–31
pregnancy: alcohol exposure during, 26; health effects during, 24;  
      preterm delivery, secondhand smoking and, 22
premature death, 24
Prevent20 Coalition, 44, 45
promotion: bans on, 11, 19, 35; surreptitious, 19
prostate cancer, deaths from, 29
Protocol to Eliminate Illicit Trade in Tobacco Products, 38
psyche, health effects on, 24
public outdoor spaces, smoke-free, 11
public places, smoking in, 40
public relations, tobacco industry’s use of, 49
Qatar, quitting in, 36
quit lines, 36, 42
quitting: age at, 36; effects of, over time, 37; immediate effects of, 36, 37;  
      reduced death risk from, 36; resources for, 36; strategies for, 36;  
      taxation and, 36. See also smoking cessation
renal failure, 24
reproductive effects, secondhand smoking and, 22
respiratory illness, secondhand smoking and, 22
Russia: alcohol and tobacco use in, 26;  
                cigarette manufacturing in, 17;  
                quitting in, 36
Rwanda, tobacco industry’s bribes in, 49
schizophrenia, tobacco use and, 26
schools, anti-tobacco initiatives in, 43
science, tobacco industry’s undermining of, 48, 49
SDGs. See Sustainable Development Goals
secondhand smoke, 22–24; deaths from, 22, 28; diseases related to, 22;  
      exposure to, by socioeconomic status, 23; health effects of, 40;  
      prevalence of, 10; sources of, 22, 23; years of life lost from, 22
Senegal: mass media campaign in, 42;  
                   quitting in, 36;  
                   secondhand smoke exposure in, 23
Serious Fraud Office (UK), 49
skeletal system, health effects on, 24
skin, health effects on, 24
smoke-free policies, 10, 22, 40–41, 52; best practices in, 41;  
      countries implementing, 35














smoking: economic cost of, 30; economic disparities and, 31; global, 10;  
      smoking, history of, 14; prevalence of, 20–21; social unacceptability of, 40;  
      surreptitious promotion of, 19
smoking areas, designated, ineffectiveness of, 40, 41
smoking bans, ENDS and, 47
smoking cessation programs, at TB and HIV clinics, 26. See also quitting
smuggling, 17, 38, 39
social costs, 10, 30–31
social media, 42
South Africa, tobacco industry monitoring in, 48
sponsorship bans, 11, 19, 35
Sri Lanka, tobacco industry monitoring in, 48
stroke, 24; deaths from; quitting and, 37; secondhand smoking and, 22
sub-Saharan Africa: secondhand smoke in, 22;  
                 smoking prevalence in, 20, 21, 28–29;  
                 tobacco use monitoring in, 20
Sudden Infant Death Syndrome, secondhand smoking and, 22
surgery, health effects on, 24
sustainable development, tobacco’s harms to, 30
Sustainable Development Goals, 34
tank style e-cigarettes, 47
Tanzania, environmental degradation in, 15
taxes, 38–39, 44; countries using, in cessation programs, 35; ENDS and, 47;  
      global implementation of, 39; global revenue growth from, 35; increasing, 20, 34; 
      multi-sectoral approach to, 50; politics of, 11; smuggling and, 38, 39;  
      tobacco industry reports on, 38
teeth, health effects on, 24
testimonials, 42
text messaging, 42
Thailand, quitting in, 36
thirdhand smoke, 40
throat, health effects on, 24
throat cancer, quitting and, 37
tobacco: addiction to, 16, 30–31; attractiveness of, as product, 16; cycle of, 10;  
      deaths from, 10; demand for, building, 18; economic cost of, to society, 10; 
      economic disparities and, 30–31; epidemic of, addressing, 10;  
      global consumption of, decrease in, 10; global spread of, 14; global use of, 52; 
      health effects from, 24–25; market for, shifts in, 10; marketed as candy, 18;  
      poverty cycle and, 30–31; product standards for, 16; taxation of, 10, 11;  
      taxes on, financing development programs through, 34; warnings on, 18
Tobacco Atlas (VS and ACS), 44
tobaccoatlas.org, 10
tobacco control: commitment to, 52; countries participating in, 35;  
      effect of, on smallholder farmers, 14; effects of, 48; extension of, 47;  
      global strategy for, 34–35; governmental indifference to, 52;  
      improvements in, 10; job losses and, 16;  litigation and, 51;  
      marketing regulations and, 18; measuring progress of, 50;   
      multi-sectoral approach to, 50; optimism about, 52–53;  
      policy implementation of, 53; return on investment from, 50;  
      skill sets for, 50; undermining of, 17
Tobacco Control Governance in Sub-Saharan Africa, 45
tobacco farmers: alternative livelihoods for, 14; benefits for, 14; exploitation of, 10; 
      health hazards for, 14; profits of, for smallholders, 14
tobacco farming, 10, 14–15; environmental degradation from, 15;  
      opportunity costs of, 14; shifting to lowest-HDI countries, 14
tobacco industry: advertising by, in low-HDI countries, 20; in Africa, marketing  
      by, 28; claims of, on increased taxation, 38; combating tobacco control,  
      strategies for, 48–49; countering of, 50–51; deception by, 10; focus of, on 
      maximizing profits, 16; front groups for, 49; global consolidation in, 16;  
      hijacking legislative processes, 49; interfering with legislation, 44; litigation  
      and, 49, 50, 51; lobbying by, 49; marketing to vulnerable groups, 10; media  
      manipulation by, 49; monitoring of, 48; partnerships countering, 44–45; 
      privatization in, 16; public relations and, 49; reallocating marketing  
      resources, 18; undermining public health efforts, 10, 14, 49; undermining 
      science, 49; venue shopping by, 51
tobacco labeling, regulation of, 11
tobacco leaf, 14
tobacco manufacturing, 16–17; factory locations for, 17; regulation of, 11
tobacco marketing, regulation of, 18–19
tobacco monitoring, by region and HDI classification, 21
tobacco packaging, regulation of, 11
tobacco production, by volume, 15
tobacco products: jurisdiction over (US), 16; plain, 18, 19;  
      standardized, 18, 19
tobacco regulation, wheel of, 11
tobacco use: monitoring of, in low-HDI countries, 20; regulation of, 11;  
      social cost of, 30–31
tracheal cancer, deaths from, 25
trade agreements, 51
tuberculosis, deaths from, 25, 26
Turkey: mass media campaigns in, 43;  
                menthol ban in, 16;  
                quitting in, 36;  
                secondhand smoke in, 22, 23;  
                smoke-free legislation in, 40, 41
Uganda: quitting in, 36;  
                  secondhand smoke exposure in, 23
Ukraine, quitting in, 36
unintended consequences, 16
United Arab Emirates: cigarette manufacturing in, 17;  
                     water pipe bans in, 40
United Kingdom: Serious Fraud Office in, 49;  
            taxes and smuggling in, 39;  
            tobacco industry monitoring in, 48
United Nations: non-communicable disease targets, 34;  
      Political Declaration of the High-Level Meeting of the United Nations  
      General Assembly, 34; sustainable development goals, 34
United Nations Development Programme, 45
United States: mental illness and adult smoking in, 27;  
     tobacco industry undermining science in, 49
urinary system, health effects on, 24
Ukraine, smoking prevalence in, by wealth groups, 31




Vietnam: quitting in, 36;  
                    social media campaigns in, 42
Vital Strategies (VS), 44
warning labels: best practices and, 19; countries implementing, 35;  
      ENDS and, 47
water pipes, 24; bans on, 40; secondhand smoke from, 22
WHO. See World Health Organization
workplaces, smoke-free, 11
World Bank, 34
World Health Organization, 10, 42; goals of, for reducing tobacco use, 10;  
      prevalence reduction target, 34, 38; voluntary targets of, for NCDs, 34;  
      WHO Cessation Index, 37
World Trade Organization, 50, 51
wounds, health effects on, 24
“W” for Warning (WHO MPOWER), 42
young adults, marketing to, 18
youth: cessation messages for, 36; marketing to, 46; smoking prevalence of, 20; 
      taxation policies and, 38
Zambia, smallholder profits in, 14
Tobacco kills nearly 8 million people each year, and the costs of tobacco use amount to almost 2 percent of the 
world’s combined gross domestic product (GDP), or approximately 2 trillion in purchasing power parity (PPP) 
dollars. Yet we have proven tools to fight this scourge at every single stage of a tobacco product’s existence,  
such as banning all tobacco additives or raising excise taxes to make these products unaffordable. 
 
We must take the initiative to use these interventions more vigorously. This will require  governments, civil society, 
researchers and other key stakeholders to work together to implement and enforce them effectively. The new 
sixth edition of The Tobacco Atlas is a resource providing data both on the scope and magnitude of the evolving 
tobacco epidemic, and on these proven solutions as they are being applied. 
Please visit our companion website tobaccoatlas.org for much more content, country fact sheets,  
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